delta.rank,pval,level,nseqs,term,name,p.adj
0,5.26E-37,2,798,GO:0044281,small molecule metabolic process,0
0,1.83E-29,5,430,GO:0019752;GO:0043436;GO:0006082,organic acid metabolic process,0
0,6.78E-23,5,201,GO:0034660,ncRNA metabolic process,0
0,1.78E-21,5,430,GO:0006396,RNA processing,0
0,3.76E-20,2,128,GO:0034470,ncRNA processing,0
0,1.53E-19,2,234,GO:0005975,carbohydrate metabolic process,0
0,5.41E-17,2,85,GO:0006364;GO:0016072,rRNA metabolic process,0
0,4.33E-16,2,205,GO:0006520,cellular amino acid metabolic process,0
0,4.03E-13,2,206,GO:0051186,cofactor metabolic process,0
0,2.69E-12,2,171,GO:0032787,monocarboxylic acid metabolic process,0
0,5.04E-12,2,29,GO:0008033,tRNA processing,0
0,2.49E-11,3,253,GO:0017144,drug metabolic process,0
0,3.34E-11,2,83,GO:0019318;GO:0005996,monosaccharide metabolic process,0
0,1.15E-10,3,59,GO:0046395;GO:0016054,organic acid catabolic process,0
0,1.17E-10,6,83,GO:0006399,tRNA metabolic process,0
0,1.20E-10,2,330,GO:1901566,organonitrogen compound biosynthetic process,0
0,1.30E-10,2,85,GO:0016999,antibiotic metabolic process,0
0,1.93E-10,2,170,GO:0090407,organophosphate biosynthetic process,0
0,2.96E-10,3,268,GO:0019637,organophosphate metabolic process,0
0,3.32E-10,2,46,GO:0006099;GO:0006101;GO:0072350,citrate metabolic process,0
0,3.96E-10,2,127,GO:1901605,alpha-amino acid metabolic process,0
0,5.46E-10,3,121,GO:0009152;GO:0006164;GO:0009260;GO:1901293;GO:0009165;GO:0072522;GO:0046390,nucleoside phosphate biosynthetic process,0
0,1.38E-09,4,197,GO:0006753;GO:0055086;GO:0009117,nucleobase-containing small molecule metabolic process,0
0,3.27E-09,3,21,GO:0009451,RNA modification,0
0,3.83E-09,3,109,GO:0006631,fatty acid metabolic process,0
0,1.27E-08,3,203,GO:0044283,small molecule biosynthetic process,0
0,1.48E-08,2,42,GO:0043648,dicarboxylic acid metabolic process,0
0,1.58E-08,2,143,GO:0009150;GO:0006163;GO:0009259;GO:0072521;GO:0019693,purine-containing compound metabolic process,0
0,2.13E-08,2,88,GO:0044282,small molecule catabolic process,0
0,2.53E-08,2,469,GO:0006796;GO:0006793,phosphorus metabolic process,0
0,2.68E-08,2,216,GO:0008380,RNA splicing,0
0,3.89E-08,2,229,GO:1901135,carbohydrate derivative metabolic process,0
0,4.13E-08,3,1305,GO:0034654;GO:0018130;GO:0019438;GO:1901362;GO:0034645;GO:0009059,organic cyclic compound biosynthetic process,0
0,4.57E-08,3,44,GO:0016052,carbohydrate catabolic process,0
0,5.16E-08,2,168,GO:0018193,peptidyl-amino acid modification,0
0,5.56E-08,2,102,GO:0051188,cofactor biosynthetic process,0
0,6.18E-08,4,71,GO:0006913;GO:0051169,nuclear transport,0
0,1.75E-07,2,7,GO:0018065,protein-cofactor linkage,0
0,2.30E-07,5,83,GO:0051028;GO:0050658;GO:0050657;GO:0051236;GO:0015931,RNA transport,0
0,2.34E-07,2,52,GO:0006575,cellular modified amino acid metabolic process,0
0,6.81E-07,3,26,GO:0072329,monocarboxylic acid catabolic process,0
0,6.83E-07,2,357,GO:0006397;GO:0016071,mRNA metabolic process,0
0,9.11E-07,2,20,GO:0006635;GO:0009062;GO:0019395;GO:0034440,fatty acid oxidation,0
0,1.39E-06,2,40,GO:0006006,glucose metabolic process,0
0,1.41E-06,2,136,GO:0046394;GO:0016053,carboxylic acid biosynthetic process,0
0,2.23E-06,3,18,GO:0001539,cilium or flagellum-dependent cell motility,0
0,2.31E-06,4,39,GO:0007005,mitochondrion organization,0
0,2.59E-06,3,105,GO:0006732,coenzyme metabolic process,0
0,2.61E-06,2,27,GO:0033044,regulation of chromosome organization,0
0,2.86E-06,2,208,GO:0006091;GO:0055114,generation of precursor metabolites and energy,0
0,3.01E-06,2,11,GO:0006760;GO:0046653,folic acid-containing compound metabolic process,0
0,3.81E-06,2,158,GO:0007018,microtubule-based movement,0
0,3.84E-06,3,14,GO:0072528;GO:0006221,pyrimidine-containing compound biosynthetic process,0
0,4.30E-06,2,51,GO:0009064,glutamine family amino acid metabolic process,0
0,6.01E-06,2,402,GO:0006629,lipid metabolic process,0.000892857
0,4.65E-06,3,92,GO:0006790,sulfur compound metabolic process,0.000909091
0,7.66E-06,2,254,GO:0044255,cellular lipid metabolic process,0.003389831
0,7.48E-06,4,753,GO:0006351;GO:0097659;GO:0032774,RNA biosynthetic process,0.003448276
0,6.98E-06,2,572,GO:1901575;GO:0009056;GO:0044248,catabolic process,0.003508772
0,8.42E-06,3,8,GO:0006189;GO:0006188;GO:0046040,IMP biosynthetic process,0.004098361
0,8.17E-06,3,63,GO:0022618;GO:0071826,ribonucleoprotein complex subunit organization,0.004166667
0,1.17E-05,3,12,GO:0009081,branched-chain amino acid metabolic process,0.004761905
0,1.14E-05,2,126,GO:1901137,carbohydrate derivative biosynthetic process,0.00483871
0,1.62E-05,2,48,GO:0006475;GO:0006473;GO:0043543,protein acylation,0.005072464
0,1.55E-05,2,9,GO:0031365,N-terminal protein amino acid modification,0.005147059
0,2.62E-05,7,10,GO:2001251,negative regulation of chromosome organization,0.005194805
0,1.49E-05,3,157,GO:0008610,lipid biosynthetic process,0.005223881
0,2.48E-05,2,20,GO:0072527;GO:0006220,pyrimidine-containing compound metabolic process,0.005263158
0,1.31E-05,4,39,GO:0034097,response to cytokine,0.00530303
0,2.25E-05,9,5,GO:0000460,maturation of 5.8S rRNA,0.005333333
0,1.29E-05,2,20,GO:0051983,regulation of chromosome segregation,0.005384615
0,2.21E-05,3,64,GO:0009108,coenzyme biosynthetic process,0.005405405
0,1.24E-05,3,38,GO:0044264;GO:0005976,polysaccharide metabolic process,0.00546875
0,2.18E-05,2,51,GO:0006112;GO:0015980,energy derivation by oxidation of organic compounds,0.005479452
0,2.13E-05,2,25,GO:0030258,lipid modification,0.005555556
0,2.10E-05,2,251,GO:0007017,microtubule-based process,0.005633803
0,1.90E-05,3,37,GO:0009636,response to toxic substance,0.005714286
0,2.75E-05,5,14,GO:0009156;GO:0009124;GO:0009161;GO:0009123,ribonucleoside monophosphate biosynthetic process,0.005769231
0,2.80E-05,3,8,GO:0006105,succinate metabolic process,0.006329114
0,3.62E-05,3,26,GO:0006839,mitochondrial transport,0.006707317
0,3.50E-05,6,15,GO:0030071;GO:0010965;GO:1902099;GO:0033047;GO:1905818;GO:0033045,regulation of sister chromatid segregation,0.006790123
0,3.33E-05,4,195,GO:0043603,cellular amide metabolic process,0.006875
0,3.92E-05,3,16,GO:0042558,pteridine-containing compound metabolic process,0.007228916
0,4.09E-05,2,55,GO:0006418;GO:0043039;GO:0043038,amino acid activation,0.007738095
0,4.73E-05,2,7,GO:0006561;GO:0006560,proline metabolic process,0.00862069
0,4.66E-05,2,67,GO:0044262,cellular carbohydrate metabolic process,0.00872093
0,4.62E-05,3,35,GO:0009063;GO:1901606,cellular amino acid catabolic process,0.008823529
0,4.90E-05,5,77,GO:0006754;GO:0009206;GO:0046034;GO:0009145;GO:0009201;GO:0009205;GO:0009142;GO:0009144;GO:0009199;GO:0009141,nucleoside triphosphate metabolic process,0.008888889
0,4.88E-05,5,29,GO:0005977;GO:0006073;GO:0044042,cellular glucan metabolic process,0.008988764
0,4.81E-05,4,22,GO:0010001,glial cell differentiation,0.009090909
0,5.86E-05,3,1209,GO:0006355;GO:1903506;GO:2001141;GO:0051252;GO:0019219,regulation of nucleobase-containing compound metabolic process,0.01043956
0,6.06E-05,3,9,GO:0005978;GO:0009250,glycogen biosynthetic process,0.010638298
0,6.89E-05,5,10,GO:0007094;GO:0045841;GO:0071173;GO:0071174;GO:1902100;GO:2000816;GO:0031577;GO:0033048;GO:1905819;GO:0033046;GO:0045839;GO:0051985,spindle checkpoint,0.010714286
0,6.01E-05,3,5,GO:0006400,tRNA modification,0.010752688
0,6.68E-05,4,9,GO:0046320,regulation of fatty acid oxidation,0.010824742
0,5.99E-05,4,9,GO:0071456;GO:0036294;GO:0071453,cellular response to hypoxia,0.010869565
0,6.39E-05,4,11,GO:0000272,polysaccharide catabolic process,0.0109375
0,7.67E-05,2,26,GO:0009112,nucleobase metabolic process,0.011
0,6.35E-05,4,17,GO:0050905,neuromuscular process,0.011052632
0,7.47E-05,5,47,GO:0006096;GO:0006757;GO:0009166;GO:0019359;GO:0042866;GO:0006165;GO:0046031;GO:0009132;GO:0046939;GO:0009179;GO:0009135;GO:0009185;GO:1901292;GO:0019363;GO:0006090,nucleoside phosphate catabolic process,0.011111111
0,8.62E-05,2,22,GO:0022613;GO:0044085;GO:0042254,cellular component biogenesis,0.012871287
0,9.66E-05,3,9,GO:0006626,protein targeting to mitochondrion,0.013592233
0,9.34E-05,7,32,GO:0018279;GO:0006487;GO:0018196,protein N-linked glycosylation,0.01372549
0,0.000107235,5,18,GO:0006953;GO:0002526,acute inflammatory response,0.014761905
0,0.000102236,3,22,GO:0046148,pigment biosynthetic process,0.014903846
0,0.000112833,4,771,GO:0006464;GO:0036211;GO:0044267;GO:0043412,cellular protein metabolic process,0.015566038
0,0.000125261,5,14,GO:0046112,nucleobase biosynthetic process,0.01682243
0,0.000142762,2,8,GO:0006607;GO:0006610,NLS-bearing protein import into nucleus,0.017272727
0,0.000142022,2,8,GO:0000245,spliceosomal complex assembly,0.017431193
0,0.000148752,2,46,GO:0048534,hematopoietic or lymphoid organ development,0.017567568
0,0.000135642,2,15,GO:0019217,regulation of fatty acid metabolic process,0.017592593
0,0.000151057,5,13,GO:0009084,glutamine family amino acid biosynthetic process,0.017857143
0,0.000167428,2,37,GO:0006914;GO:0061919,autophagy,0.019298246
0,0.000164718,2,10,GO:0009168;GO:0009127;GO:0009167;GO:0009126,purine ribonucleoside monophosphate biosynthetic process,0.019469027
0,0.00018571,2,8,GO:0009083,branched-chain amino acid catabolic process,0.020869565
0,0.000197297,2,30,GO:0042440,pigment metabolic process,0.02112069
0,0.000199799,2,7,GO:1902275,regulation of chromatin organization,0.021367521
0,0.000207504,2,53,GO:1901607;GO:0008652,cellular amino acid biosynthetic process,0.023728814
0,0.000214404,2,6,GO:0042559,pteridine-containing compound biosynthetic process,0.02394958
0,0.000216681,3,14,GO:0071345,cellular response to cytokine stimulus,0.024166667
0,0.000245807,2,13,GO:0007338;GO:0009566,fertilization,0.024193548
0,0.000242024,7,10,GO:0051784,negative regulation of nuclear division,0.024390244
0,0.000238053,6,7,GO:0001522,pseudouridine synthesis,0.024590164
0,0.00022831,2,56,GO:0042737,drug catabolic process,0.024793388
0,0.000256198,4,6,GO:0045682,regulation of epidermis development,0.0256
0,0.000276247,3,5,GO:0003407,neural retina development,0.026984127
0,0.000337686,3,9,GO:0016180;GO:0016073,snRNA metabolic process,0.029527559
0,0.000364189,5,11,GO:0050885,neuromuscular process controlling balance,0.030232558
0,0.000391815,4,6,GO:0045582;GO:0045621,positive regulation of lymphocyte differentiation,0.030384615
0,0.000360123,2,320,GO:0065003;GO:0043933,protein-containing complex subunit organization,0.03046875
0,0.000458136,3,10,GO:0051000;GO:0032770;GO:0050999;GO:0032768,regulation of nitric-oxide synthase activity,0.034090909
0,0.000470241,3,24,GO:0042398,cellular modified amino acid biosynthetic process,0.034328358
0,0.00045794,5,15,GO:0051353;GO:0051341,regulation of oxidoreductase activity,0.034351145
0,0.000468088,3,8,GO:0035564,regulation of kidney size,0.034586466
0,0.000501923,5,11,GO:0043968,histone H2A acetylation,0.037037037
0,0.000508769,2,191,GO:0034622,cellular protein-containing complex assembly,0.037132353
0,0.000569297,6,77,GO:0018205,peptidyl-lysine modification,0.039160839
0,0.000548615,4,12,GO:0006206,pyrimidine nucleobase metabolic process,0.039285714
0,0.000560013,3,33,GO:0051168,nuclear export,0.03943662
0,0.000539767,3,116,GO:0043043;GO:0043604,amide biosynthetic process,0.039492754
0,0.000548149,7,6,GO:0032981;GO:0010257;GO:0033108,mitochondrial respiratory chain complex assembly,0.039568345
0,0.00058876,4,7,GO:0007301;GO:0030725;GO:0043063;GO:0030723,intercellular bridge organization,0.039583333
0,0.000594749,2,27,GO:0030856,regulation of epithelial cell differentiation,0.039655172
0,0.000559879,3,31,GO:0000096,sulfur amino acid metabolic process,0.039716312
0,0.000537935,6,5,GO:0006547;GO:0052803,histidine metabolic process,0.039781022
0,0.000632233,2,5,GO:0035456,response to interferon-beta,0.041438356
0,0.00063863,2,12,GO:0003264;GO:2000136,regulation of cell proliferation involved in heart morphogenesis,0.041836735
0,0.000656721,3,91,GO:0033365;GO:0072594,protein localization to organelle,0.04222973
0,0.000666807,4,21,GO:0042168;GO:0006778,porphyrin-containing compound metabolic process,0.04261745
0,0.000699773,2,159,GO:0034655;GO:0019439;GO:0044270;GO:0046700;GO:1901361,organic cyclic compound catabolic process,0.043
0,0.000709192,3,9,GO:0019218,regulation of steroid metabolic process,0.043092105
0,0.000729017,4,25,GO:0033013,tetrapyrrole metabolic process,0.043137255
0,0.000707572,3,247,GO:0006281;GO:0006974,cellular response to DNA damage stimulus,0.043377483
0,0.000743972,2,19,GO:0018022;GO:0006479;GO:0008213,protein methylation,0.043506494
0,0.000771316,2,30,GO:0007088;GO:0051783,regulation of nuclear division,0.044516129
0,0.000802432,3,70,GO:0016032;GO:0044403,viral process,0.046794872
0,0.000806637,1,116,GO:0007610,behavior,0.046815287
0,0.000841632,3,18,GO:0048496,maintenance of animal organ identity,0.048101266
0,0.000857198,4,10,GO:0000089;GO:0051323,metaphase,0.048742138
0,0.000879099,3,81,GO:0010035,response to inorganic substance,0.04875
0,0.000884511,2,17,GO:0006004,fucose metabolic process,0.048757764
0,0.000891959,4,14,GO:0072655;GO:0070585,protein localization to mitochondrion,0.049074074
0,0.000934003,2,43,GO:0016051,carbohydrate biosynthetic process,0.05152439
0,0.00095638,3,7,GO:0044550,secondary metabolite biosynthetic process,0.051807229
0,0.000932858,4,73,GO:0072330,monocarboxylic acid biosynthetic process,0.051840491
0,0.000974273,2,7,GO:0048134;GO:0007294;GO:0030716,germarium-derived oocyte fate determination,0.052095808
0,0.000952792,4,10,GO:0051303;GO:0050000,establishment of chromosome localization,0.052121212
0,0.001043287,4,7,GO:0019058,viral life cycle,0.05591716
0,0.001042336,3,7,GO:0006207;GO:0019856,'de novo' pyrimidine nucleobase biosynthetic process,0.05625
0,0.001119539,3,7,GO:0007140;GO:0140013;GO:0000280,meiotic nuclear division,0.06
0,0.001199221,2,15,GO:0001938;GO:0001936,regulation of endothelial cell proliferation,0.062138728
0,0.001170625,5,16,GO:0006750;GO:0019184,nonribosomal peptide biosynthetic process,0.062209302
0,0.001160147,3,13,GO:0006103,2-oxoglutarate metabolic process,0.062280702
0,0.001214371,3,29,GO:0030097,hemopoiesis,0.062356322
0,0.001234777,2,8,GO:0097084,vascular smooth muscle cell development,0.063714286
0,0.001254377,7,5,GO:0045907,positive regulation of vasoconstriction,0.064772727
0,0.001291077,2,66,GO:0006486;GO:0043413;GO:0070085,protein glycosylation,0.065168539
0,0.001286906,5,40,GO:0006606;GO:0017038;GO:0034504;GO:0051170,protein import,0.065536723
0,0.001338732,2,7,GO:0001942,hair follicle development,0.066483516
0,0.001318632,3,5,GO:0006012,galactose metabolic process,0.066759777
0,0.001334361,5,11,GO:0034030;GO:0034033;GO:0033866,ribonucleoside bisphosphate biosynthetic process,0.066850829
0,0.001354774,3,22,GO:0033875;GO:0034032;GO:0033865,ribonucleoside bisphosphate metabolic process,0.066939891
0,0.001333217,4,22,GO:0014014;GO:0045686;GO:0048710,negative regulation of gliogenesis,0.066944444
0,0.001375193,5,27,GO:0043687,post-translational protein modification,0.067027027
0,0.001364065,2,12,GO:0019748,secondary metabolic process,0.067119565
0,0.001421273,2,29,GO:0030510,regulation of BMP signaling pathway,0.06827957
0,0.001443567,2,37,GO:0060341,regulation of cellular localization,0.068518519
0,0.00143647,2,26,GO:0045494,photoreceptor cell maintenance,0.068617021
0,0.001433418,6,18,GO:0060253;GO:0060251;GO:0048715;GO:0048713;GO:2000974;GO:1905457;GO:2000973;GO:1901533;GO:1905456;GO:1901532;GO:0048711;GO:0045687;GO:0014015,regulation of oligodendrocyte differentiation,0.068983957
0,0.001503093,3,6,GO:0014075,response to amine,0.070263158
0,0.001578181,2,33,GO:0009066,aspartate family amino acid metabolic process,0.07408377
0,0.001628715,2,23,GO:0034599,cellular response to oxidative stress,0.074226804
0,0.001624714,2,52,GO:0050863;GO:0051249;GO:1903037;GO:0022407,regulation of lymphocyte activation,0.074611399
0,0.001643946,3,9,GO:0006370;GO:0009452;GO:0036260,7-methylguanosine RNA capping,0.074871795
0,0.00162401,3,84,GO:0006979,response to oxidative stress,0.075
0,0.001689321,4,25,GO:0014013;GO:0045685,regulation of gliogenesis,0.076530612
0,0.00175884,3,31,GO:0043269,regulation of ion transport,0.079695431
0,0.001788603,3,15,GO:0006040,amino sugar metabolic process,0.07975
0,0.001782005,5,11,GO:1990542,mitochondrial transmembrane transport,0.080150754
0,0.001771276,2,17,GO:0043967,histone H4 acetylation,0.08030303
0,0.001821267,3,55,GO:1903311,regulation of mRNA metabolic process,0.08159204
0,0.00186207,2,16,GO:0006783;GO:0006779;GO:0033014,porphyrin-containing compound biosynthetic process,0.081617647
0,0.001854451,2,16,GO:0006829,zinc ion transport,0.082019704
0,0.001845395,2,21,GO:0031124;GO:0031123,RNA 3'-end processing,0.082425743
0,0.001996443,2,23,GO:0007093,mitotic cell cycle checkpoint,0.086714976
0,0.002017153,3,8,GO:0046928;GO:0051588,regulation of neurotransmitter transport,0.087019231
0,0.001968777,2,33,GO:0097164,ammonium ion metabolic process,0.087073171
0,0.001976749,2,24,GO:0007051,spindle organization,0.087135922
0,0.002056408,3,8,GO:0005980;GO:0009251;GO:0044247;GO:0044275,cellular carbohydrate catabolic process,0.088516746
0,0.002092873,3,9,GO:0051382;GO:0051383;GO:0007079;GO:0051305;GO:0007080;GO:0051310,chromosome movement towards spindle pole,0.089761905
0,0.002196466,3,7,GO:0010575;GO:0010574,positive regulation of vascular endothelial growth factor production,0.092723005
0,0.002194737,2,16,GO:0030534,adult behavior,0.092924528
0,0.002266926,3,36,GO:0034762,regulation of transmembrane transport,0.094859813
0,0.002272563,2,13,GO:0006637;GO:0035383,acyl-CoA metabolic process,0.094883721
0,0.002288727,3,11,GO:0006805,xenobiotic metabolic process,0.095391705
0,0.002286286,2,40,GO:0051187,cofactor catabolic process,0.095833333
0,0.002394046,4,6,GO:0009258;GO:0009256;GO:0009397;GO:0043649;GO:0042219;GO:0042560,dicarboxylic acid catabolic process,0.097018349
0,0.002486693,2,41,GO:0000041,transition metal ion transport,0.097954545
0,0.002474166,1,16,GO:0043473,pigmentation,0.098401826
0,0.002519467,2,69,GO:0043065;GO:0043068;GO:0010942,positive regulation of cell death,0.09841629
0,0.002541646,4,43,GO:0006633,fatty acid biosynthetic process,0.098423423
0,0.002562535,3,476,GO:0033554;GO:0051716,cellular response to stimulus,0.1
0,0.002589115,4,44,GO:0034404,nucleobase-containing small molecule biosynthetic process,0.100223214
0,0.002604111,2,5,GO:0040018,positive regulation of multicellular organism growth,0.100444444
0,0.00264504,2,24,GO:0000236;GO:0098763,mitotic cell cycle phase,0.101327434
0,0.002678444,2,25,GO:0019827;GO:0098727,stem cell population maintenance,0.102412281
0,0.002678216,3,11,GO:0006030;GO:1901071,glucosamine-containing compound metabolic process,0.102863436
0,0.002802717,6,29,GO:0006302,double-strand break repair,0.104803493
0,0.002891186,6,6,GO:0050848,regulation of calcium-mediated signaling,0.106223176
0,0.002857819,2,16,GO:0006497,protein lipidation,0.10625
0,0.00285698,5,27,GO:0006555;GO:0009086;GO:0000097;GO:0009067,aspartate family amino acid biosynthetic process,0.106493506
0,0.002851121,2,16,GO:0033692;GO:0000271;GO:0034637,cellular carbohydrate biosynthetic process,0.10673913
0,0.002950182,2,11,GO:0008344,adult locomotory behavior,0.108333333
0,0.002973257,2,47,GO:0044272,sulfur compound biosynthetic process,0.109148936
0,0.002997181,2,391,GO:0006915;GO:0012501;GO:0008219,cell death,0.109533898
0,0.003091447,5,5,GO:0030497;GO:0042761;GO:0000038,very long-chain fatty acid biosynthetic process,0.112658228
0,0.003114763,3,6,GO:0051298,centrosome duplication,0.113655462
0,0.00312715,2,7,GO:0043508,negative regulation of JUN kinase activity,0.114225941
0,0.003207862,3,9,GO:0009220;GO:0009218,pyrimidine ribonucleotide metabolic process,0.116875
0,0.003246353,2,8,GO:0018200,peptidyl-glutamic acid modification,0.117489712
0,0.003242038,2,46,GO:0007030,Golgi organization,0.117975207
0,0.003296227,5,11,GO:0009070,serine family amino acid biosynthetic process,0.118442623
0,0.003241967,2,397,GO:0042221,response to chemical,0.11846473
0,0.003329021,2,44,GO:0120031;GO:0030031,plasma membrane bounded cell projection assembly,0.119387755
0,0.003428015,4,11,GO:0006097;GO:0046487,glyoxylate metabolic process,0.123076923
0,0.003477485,2,15,GO:0006144,purine nucleobase metabolic process,0.124698795
0,0.003475614,2,15,GO:0034968;GO:0016571,histone methylation,0.124798387
0,0.003560279,6,24,GO:0010827,regulation of glucose transmembrane transport,0.1264
0,0.003602071,5,22,GO:0006541,glutamine metabolic process,0.12689243
0,0.003717984,2,12,GO:0097746;GO:0035296,regulation of tube diameter,0.130753968
0,0.003835419,2,115,GO:0045596,negative regulation of cell differentiation,0.133661417
0,0.003827411,6,11,GO:0007052,mitotic spindle organization,0.133794466
0,0.003865953,5,110,GO:0048193,Golgi vesicle transport,0.134705882
0,0.003922627,3,55,GO:0046496;GO:0019362;GO:0006733;GO:0072524,pyridine-containing compound metabolic process,0.1359375
0,0.00400801,2,16,GO:0032963,collagen metabolic process,0.137354086
0,0.004026283,2,65,GO:0007346,regulation of mitotic cell cycle,0.137403101
0,0.004196694,4,7,GO:1905039;GO:0098656;GO:1903825,organic acid transmembrane transport,0.140540541
0,0.004233907,3,18,GO:0032868,response to insulin,0.141153846
0,0.004399563,3,46,GO:0043484;GO:0048024;GO:0050684,regulation of RNA splicing,0.143726236
0,0.004382892,2,47,GO:0051260,protein homooligomerization,0.144274809
0,0.004371198,2,9,GO:0007435;GO:0022612,salivary gland morphogenesis,0.144444444
0,0.004643606,2,5,GO:0060992,response to fungicide,0.145036765
0,0.004452762,5,22,GO:0006406;GO:0006405,RNA export from nucleus,0.145075758
0,0.004555151,4,11,GO:0007424;GO:0060541,respiratory system development,0.145149254
0,0.004615697,4,84,GO:0007399,nervous system development,0.145185185
0,0.004632366,2,18,GO:0006909,phagocytosis,0.145202952
0,0.004521142,3,39,GO:0030168,platelet activation,0.145488722
0,0.004538699,2,18,GO:0009072,aromatic amino acid family metabolic process,0.145505618
0,0.004594135,2,90,GO:0006954,inflammatory response,0.145539033
0,0.004493738,5,12,GO:0045821;GO:0006110;GO:0030813;GO:0045913;GO:0051197;GO:2001171;GO:0030811;GO:0043470;GO:0051196;GO:2001169;GO:0051193;GO:1900371;GO:1903578;GO:0030808;GO:0045981;GO:0062013;GO:0051194;GO:1900373;GO:1903580;GO:0030810;GO:1900544,regulation of ATP metabolic process,0.145660377
0,0.0048022,2,8,GO:0007638,mechanosensory behavior,0.145863309
0,0.004753208,4,15,GO:1902692;GO:0072091;GO:2000177,regulation of neural precursor cell proliferation,0.146014493
0,0.004785779,2,44,GO:0016197,endosomal transport,0.146028881
0,0.004701835,6,8,GO:0032722;GO:0032642;GO:0043619;GO:0043618;GO:0043620;GO:0071347;GO:0002248;GO:0097709;GO:0051541;GO:0042789;GO:0009299;GO:0070101;GO:0001961;GO:0070099;GO:0060760;GO:0010870;GO:0010869;GO:0032909;GO:0071634;GO:0010573,regulation of DNA-templated transcription in response to stress,0.146153846
0,0.004742207,5,10,GO:0045648;GO:0045646,regulation of erythrocyte differentiation,0.146363636
0,0.004723115,2,527,GO:0051641;GO:0046907;GO:0051649,cellular localization,0.146532847
0,0.004900211,3,36,GO:0045017,glycerolipid biosynthetic process,0.148566308
0,0.00501823,4,60,GO:0010038,response to metal ion,0.150177305
0,0.00501017,3,47,GO:0044242,cellular lipid catabolic process,0.150355872
0,0.005004236,2,62,GO:0072593,reactive oxygen species metabolic process,0.150714286
0,0.005169634,2,7,GO:0043588,skin development,0.152631579
0,0.00514381,7,12,GO:0043407,negative regulation of MAP kinase activity,0.152640845
0,0.005120605,3,33,GO:0006935;GO:0042330,taxis,0.152650177
0,0.005240928,2,15,GO:0051147,regulation of muscle cell differentiation,0.153484321
0,0.005225581,2,38,GO:0043414;GO:0032259,macromolecule methylation,0.153671329
0,0.005310253,3,6,GO:0072132,mesenchyme morphogenesis,0.154513889
0,0.005349472,2,7,GO:0007588,excretion,0.15467128
0,0.005390013,4,22,GO:0006749,glutathione metabolic process,0.154982818
0,0.005372249,4,6,GO:0046888,negative regulation of hormone secretion,0.155
0,0.005435257,6,23,GO:0006094;GO:0019319;GO:0046364,monosaccharide biosynthetic process,0.155460751
0,0.005422801,3,98,GO:0007283;GO:0048232,spermatogenesis,0.155650685
0,0.005492465,2,8,GO:0021537,telencephalon development,0.155952381
0,0.005574497,2,7,GO:0045931,positive regulation of mitotic cell cycle,0.157966102
0,0.005608178,2,17,GO:0002576,platelet degranulation,0.158952703
0,0.005649601,3,33,GO:0016573;GO:0018393;GO:0018394,internal peptidyl-lysine acetylation,0.15993266
0,0.005908453,2,15,GO:0010506,regulation of autophagy,0.165050167
0,0.005877184,2,32,GO:0042744;GO:0017001;GO:0042743,hydrogen peroxide metabolic process,0.165268456
0,0.005971863,6,9,GO:0009303;GO:0098781,ncRNA transcription,0.165833333
0,0.006163079,4,20,GO:0008361,regulation of cell size,0.170099668
0,0.006234453,3,23,GO:0010565,regulation of cellular ketone metabolic process,0.171287129
0,0.006232994,2,5,GO:0060444,branching involved in mammary gland duct morphogenesis,0.171854305
0,0.006288607,2,7,GO:0018210,peptidyl-threonine modification,0.172039474
0,0.006408911,5,7,GO:0007595,lactation,0.173856209
0,0.006379202,2,5,GO:0099120,socially cooperative development,0.174098361
0,0.006543197,2,46,GO:0008654,phospholipid biosynthetic process,0.176221498
0,0.006706125,2,136,GO:1903047,mitotic cell cycle process,0.178225806
0,0.006630984,3,78,GO:0006260,DNA replication,0.178246753
0,0.006699943,2,7,GO:0006684,sphingomyelin metabolic process,0.178802589
0,0.006802096,4,23,GO:0030518;GO:0043401,steroid hormone mediated signaling pathway,0.179487179
0,0.006780485,2,10,GO:0051646,mitochondrion localization,0.179581994
0,0.006850888,2,28,GO:0007626,locomotory behavior,0.179872204
0,0.006935565,5,5,GO:0023035,CD40 signaling pathway,0.181369427
0,0.007261812,4,5,GO:0030950,establishment or maintenance of actin cytoskeleton polarity,0.185514019
0,0.007255288,3,44,GO:0010948;GO:0045930,negative regulation of mitotic cell cycle,0.1859375
0,0.007158906,6,5,GO:0001510,RNA methylation,0.186666667
0,0.007248162,4,5,GO:0048311,mitochondrion distribution,0.186949686
0,0.007223315,3,21,GO:0031960;GO:0048545,response to steroid hormone,0.187025316
0,0.007246891,2,5,GO:0060977,coronary vasculature morphogenesis,0.187539432
0,0.007509933,2,60,GO:0046486,glycerolipid metabolic process,0.191925466
0,0.007608204,2,6,GO:0042135,neurotransmitter catabolic process,0.193209877
0,0.007599098,3,10,GO:0051084;GO:0006458,'de novo' protein folding,0.193653251
0,0.007756817,2,8,GO:0050847,progesterone receptor signaling pathway,0.194969512
0,0.00779822,2,39,GO:0001666;GO:0036293;GO:0070482,response to oxygen levels,0.195440729
0,0.007755864,4,14,GO:0045580;GO:0045619,regulation of T cell differentiation,0.195565749
0,0.007842931,2,47,GO:0019216,regulation of lipid metabolic process,0.195757576
0,0.007722141,2,49,GO:0001505,regulation of neurotransmitter levels,0.195846154
0,0.007862286,4,5,GO:0050810,regulation of steroid biosynthetic process,0.196072508
0,0.008030392,4,7,GO:0046886;GO:0032352;GO:0046885;GO:0032350,regulation of hormone metabolic process,0.199548193
0,0.008214316,2,26,GO:0006730,one-carbon metabolic process,0.199554896
0,0.008188596,2,15,GO:0003156,regulation of animal organ formation,0.199702381
0,0.008188596,6,15,GO:2000826,regulation of heart morphogenesis,0.199702381
0,0.008084932,2,77,GO:0070925,organelle assembly,0.19984985
0,0.008174861,2,31,GO:0051054,positive regulation of DNA metabolic process,0.200748503
0,0.008286079,2,8,GO:0021545;GO:0021675,cranial nerve development,0.201331361
0,0.008522323,2,10,GO:0051924,regulation of calcium ion transport,0.20619469
0,0.00859781,3,20,GO:0001709,cell fate determination,0.206451613
0,0.008564489,3,18,GO:0006306;GO:0006305;GO:0044728;GO:0006304,DNA modification,0.206617647
0,0.00873032,2,31,GO:0009755,hormone-mediated signaling pathway,0.209649123
0,0.008915943,4,14,GO:0006576;GO:0044106;GO:0009308,amine metabolic process,0.211918605
0,0.008903083,2,18,GO:0048771,tissue remodeling,0.212390671
0,0.009102147,2,37,GO:1903046,meiotic cell cycle process,0.214782609
0,0.009185414,2,8,GO:0006534,cysteine metabolic process,0.215273775
0,0.009175708,2,88,GO:0016042,lipid catabolic process,0.215895954
0,0.009411025,2,6,GO:1901068,guanosine-containing compound metabolic process,0.218571429
0,0.009375312,7,10,GO:0002028,regulation of sodium ion transport,0.218624642
0,0.009487374,2,26,GO:1903707,negative regulation of hemopoiesis,0.219230769
0,0.009363319,2,8,GO:0030952,establishment or maintenance of cytoskeleton polarity,0.219252874
0,0.009755462,2,1023,GO:0048523;GO:0048519,negative regulation of biological process,0.223796034
0,0.010013619,2,8,GO:0000731,DNA synthesis involved in DNA repair,0.228813559
0,0.010195538,2,11,GO:0034612,response to tumor necrosis factor,0.231179775
0,0.010171626,2,8,GO:0070555,response to interleukin-1,0.231408451
0,0.01028881,2,22,GO:0035176;GO:0051703,intraspecies interaction between organisms,0.234313725
0,0.010401217,2,15,GO:0048640,negative regulation of developmental growth,0.235893855
0,0.010636608,2,57,GO:0006892,post-Golgi vesicle-mediated transport,0.240668524
0,0.010734317,3,10,GO:0034312;GO:0046173,polyol biosynthetic process,0.242777778
0,0.010958184,2,13,GO:0048285,organelle fission,0.246398892
0,0.011274106,3,156,GO:0055085,transmembrane transport,0.251928375
0,0.011424731,6,22,GO:0055072,iron ion homeostasis,0.252459016
0,0.011396614,2,6,GO:0010172,embryonic body morphogenesis,0.253013699
0,0.011396071,2,8,GO:0042255,ribosome assembly,0.253708791
0,0.011592662,3,5,GO:0061333,renal tubule morphogenesis,0.254065041
0,0.011571369,2,465,GO:0022607,cellular component assembly,0.254483696
0,0.011558174,4,18,GO:0045740,positive regulation of DNA replication,0.255040872
0,0.011717281,4,50,GO:1903706,regulation of hemopoiesis,0.255675676
0,0.011756662,3,13,GO:0046890,regulation of lipid biosynthetic process,0.255929919
0,0.012000795,2,11,GO:0006140;GO:1900542,regulation of nucleotide metabolic process,0.260215054
0,0.012068966,3,23,GO:0042730;GO:0030195;GO:0030193;GO:0050819;GO:0061045;GO:1900047;GO:0050818;GO:1900046;GO:1903035,regulation of coagulation,0.261394102
0,0.012683752,2,75,GO:0050878,regulation of body fluid levels,0.270954907
0,0.012610908,3,7,GO:0006611,protein export from nucleus,0.270989305
0,0.01266824,2,138,GO:0008285,negative regulation of cell population proliferation,0.271010638
0,0.012648203,2,6,GO:0021861;GO:0060019;GO:2000978;GO:2000977,radial glial cell differentiation,0.271066667
0,0.012754372,2,878,GO:0071702;GO:0071705;GO:0015031;GO:0015833;GO:0045184;GO:0042886;GO:0008104;GO:0033036,organic substance transport,0.271693122
0,0.01287257,4,7,GO:0060968,regulation of gene silencing,0.272631579
0,0.012975592,3,25,GO:0009069,serine family amino acid metabolic process,0.273167539
0,0.012866191,3,36,GO:0072525,pyridine-containing compound biosynthetic process,0.273218997
0,0.012966353,4,130,GO:0006518,peptide metabolic process,0.273753281
0,0.013150989,4,7,GO:0008582;GO:1904396,regulation of synaptic growth at neuromuscular junction,0.273766234
0,0.013139844,2,828,GO:0006950,response to stress,0.274088542
0,0.013097663,2,10,GO:0046822,regulation of nucleocytoplasmic transport,0.274281984
0,0.013401891,3,11,GO:0043046;GO:0034587,piRNA metabolic process,0.277720207
0,0.013460978,2,8,GO:0035050;GO:0008078,embryonic heart tube development,0.278165375
0,0.013700912,2,6,GO:0060037,pharyngeal system development,0.282087629
0,0.014063499,2,27,GO:0008340,determination of adult lifespan,0.282531646
0,0.013998536,3,7,GO:0035019,somatic stem cell population maintenance,0.282614213
0,0.013977067,2,5,GO:0007029,endoplasmic reticulum organization,0.282951654
0,0.013770886,4,6,GO:0045069;GO:1903900,regulation of viral life cycle,0.283161954
0,0.013841301,5,7,GO:0001885,endothelial cell development,0.283333333
0,0.013969054,3,13,GO:0030901,midbrain development,0.283673469
0,0.013962158,2,7,GO:0043462,regulation of ATPase activity,0.284398977
0,0.014220837,4,10,GO:0007589,body fluid secretion,0.285227273
0,0.014438161,2,20,GO:0010959,regulation of metal ion transport,0.287153652
0,0.014509763,2,26,GO:0006081,cellular aldehyde metabolic process,0.287437186
0,0.014577363,4,6,GO:0006488;GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,0.288345865
0,0.014814142,6,7,GO:0006891,intra-Golgi vesicle-mediated transport,0.291
0,0.015097481,2,13,GO:0045176,apical protein localization,0.291955446
0,0.015219144,2,11,GO:0048538,thymus development,0.291995074
0,0.015077899,2,5,GO:0015696,ammonium transport,0.292059553
0,0.015184147,3,14,GO:0030032;GO:0097581,lamellipodium assembly,0.292222222
0,0.015053109,2,5,GO:0019228,neuronal action potential,0.292537313
0,0.015309577,2,23,GO:0007033,vacuole organization,0.292874693
0,0.01501885,6,16,GO:0042102;GO:0050671;GO:0032946;GO:0070665,positive regulation of lymphocyte proliferation,0.292892768
0,0.015445995,3,5,GO:0090307,mitotic spindle assembly,0.293995098
0,0.015578721,4,5,GO:0051645,Golgi localization,0.295243902
0,0.015615276,3,16,GO:0051225,spindle assembly,0.295255474
0,0.015564182,2,15,GO:0045478,fusome organization,0.295843521
0,0.015927823,4,14,GO:0051017;GO:0061572,actin filament bundle organization,0.299878935
0,0.015915817,2,7,GO:0009113,purine nucleobase biosynthetic process,0.300606796
0,0.016102565,3,11,GO:0007040;GO:0080171,lytic vacuole organization,0.300961538
0,0.016075244,2,26,GO:0000302,response to reactive oxygen species,0.301084337
0,0.016057431,2,11,GO:0022405;GO:0022404,hair cycle process,0.301449275
0,0.01630993,2,153,GO:0006325,chromatin organization,0.301789976
0,0.016239917,3,46,GO:0000075,cell cycle checkpoint,0.301794258
0,0.016410148,2,7,GO:0006884,cell volume homeostasis,0.30202381
0,0.016224679,3,12,GO:0006536,glutamate metabolic process,0.302038369
0,0.016475885,4,13,GO:0042059;GO:1901185,negative regulation of ERBB signaling pathway,0.302132701
0,0.016459751,2,18,GO:0007204;GO:0051480,regulation of cytosolic calcium ion concentration,0.302375297
0,0.016558494,2,17,GO:0043488;GO:0043487;GO:0061013,regulation of mRNA catabolic process,0.302600473
0,0.016866358,6,28,GO:0010638,positive regulation of organelle organization,0.306367925
0,0.017063648,5,7,GO:0046949;GO:0035337;GO:0071616;GO:0035384,acyl-CoA biosynthetic process,0.309176471
0,0.017346504,5,6,GO:0009060;GO:0045333,aerobic respiration,0.311241218
0,0.017323213,4,17,GO:0043270,positive regulation of ion transport,0.311502347
0,0.017615343,5,9,GO:0009065,glutamine family amino acid catabolic process,0.312674419
0,0.017572788,2,9,GO:0006301,postreplication repair,0.313053613
0,0.017518077,7,92,GO:0043066;GO:0043069;GO:0060548,negative regulation of cell death,0.313084112
0,0.017700391,4,25,GO:0006767,water-soluble vitamin metabolic process,0.313225058
0,0.017868477,2,66,GO:0016570;GO:0016569,covalent chromatin modification,0.315046296
0,0.018109253,2,38,GO:0006650,glycerophospholipid metabolic process,0.31624424
0,0.018081357,4,22,GO:0030968,endoplasmic reticulum unfolded protein response,0.316859122
0,0.018479522,2,11,GO:0021510,spinal cord development,0.319336384
0,0.018474323,4,6,GO:0030042;GO:0051261,protein depolymerization,0.320068807
0,0.018462558,3,6,GO:0015919;GO:0016558,peroxisomal membrane transport,0.320574713
0,0.018751917,2,7,GO:0019432;GO:0046463;GO:0046460,acylglycerol biosynthetic process,0.322031963
0,0.018810499,4,17,GO:0002064,epithelial cell development,0.323006834
0,0.019057151,2,9,GO:0051492;GO:0032231;GO:0110020,regulation of actin filament bundle assembly,0.324716553
0,0.01902008,3,17,GO:1901570,fatty acid derivative biosynthetic process,0.325227273
0,0.019165821,2,6,GO:0051156,glucose 6-phosphate metabolic process,0.325452489
0,0.019382119,4,5,GO:0070828,heterochromatin organization,0.327539503
0,0.019904451,2,55,GO:0035239,tube morphogenesis,0.335022523
0,0.019998686,5,32,GO:0051592,response to calcium ion,0.336516854
0,0.020126679,2,69,GO:0045454,cell redox homeostasis,0.337136465
0,0.020418643,3,9,GO:0061982,meiosis I cell cycle process,0.338752784
0,0.020367073,5,5,GO:0031179,peptide modification,0.338950893
0,0.020678501,3,25,GO:1901991;GO:1901988,negative regulation of mitotic cell cycle phase transition,0.341222222
0,0.020779979,2,7,GO:0097150,neuronal stem cell population maintenance,0.341796009
0,0.020939228,7,5,GO:2001252,positive regulation of chromosome organization,0.342384106
0,0.020981638,5,9,GO:0001959;GO:0060759,regulation of cytokine-mediated signaling pathway,0.342621145
0,0.020900188,6,6,GO:0033135;GO:0033138,regulation of peptidyl-serine phosphorylation,0.342809735
0,0.021494195,2,274,GO:0042127,regulation of cell population proliferation,0.35021978
0,0.021794479,2,60,GO:0051052,regulation of DNA metabolic process,0.353947368
0,0.022219389,2,235,GO:0042981;GO:0043067;GO:0010941,regulation of cell death,0.357549234
0,0.022332293,2,137,GO:0008284,positive regulation of cell population proliferation,0.358624454
0,0.022476654,3,6,GO:0022011;GO:0032292,myelination in peripheral nervous system,0.35867679
0,0.022476654,3,6,GO:0032233,positive regulation of actin filament bundle assembly,0.35867679
0,0.022472478,3,8,GO:0019229,regulation of vasoconstriction,0.360239651
0,0.022732434,4,24,GO:0042129;GO:0050670;GO:0032944,regulation of lymphocyte proliferation,0.360714286
0,0.022841355,2,28,GO:0045639;GO:0045637;GO:1903708,positive regulation of hemopoiesis,0.361555076
0,0.023029314,3,38,GO:0030522,intracellular receptor signaling pathway,0.363577586
0,0.023190935,2,16,GO:0007349,cellularization,0.36483871
0,0.023283624,2,45,GO:0050870;GO:0051251;GO:1903039;GO:0002696;GO:0050867;GO:0022409;GO:0045785,positive regulation of cell adhesion,0.365021459
0,0.023477235,2,143,GO:0033043,regulation of organelle organization,0.36684435
0,0.023440608,4,25,GO:0000079;GO:1904029,regulation of cyclin-dependent protein serine/threonine kinase activity,0.366880342
0,0.023387862,6,12,GO:0046782;GO:0050434;GO:0048524,positive regulation of viral process,0.366916488
0,0.023678374,2,5,GO:0051149,positive regulation of muscle cell differentiation,0.367409766
0,0.023673374,2,99,GO:0010817,regulation of hormone levels,0.368085106
0,0.023826374,3,30,GO:0070663,regulation of leukocyte proliferation,0.368538136
0,0.024025002,3,5,GO:0035338;GO:0035336,long-chain fatty-acyl-CoA biosynthetic process,0.368736842
0,0.024005641,5,196,GO:0006468;GO:0016310,phosphorylation,0.369092827
0,0.023937307,3,5,GO:0008156,negative regulation of DNA replication,0.369133192
0,0.024287022,2,5,GO:0021984,adenohypophysis development,0.3708159
0,0.024238915,2,24,GO:0046474,glycerophospholipid biosynthetic process,0.371428571
0,0.02448285,2,6,GO:0006026,aminoglycan catabolic process,0.372755741
0,0.024609447,2,6,GO:0006563,L-serine metabolic process,0.3740625
0,0.024801861,2,8,GO:0043574;GO:0006625;GO:0072663;GO:0072662,peroxisomal transport,0.375363825
0,0.025014622,2,97,GO:0048729;GO:0002009,tissue morphogenesis,0.37873444
0,0.025364534,2,22,GO:0046165,alcohol biosynthetic process,0.383747412
0,0.025491499,4,8,GO:0048864,stem cell development,0.384226804
0,0.02558207,3,6,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,0.38436214
0,0.025463184,3,34,GO:0006898,receptor-mediated endocytosis,0.384607438
0,0.025656361,4,446,GO:0016192,vesicle-mediated transport,0.384804928
0,0.026238351,2,23,GO:0051262,protein tetramerization,0.391290984
0,0.026393903,2,11,GO:0007031,peroxisome organization,0.392740286
0,0.026680639,4,18,GO:0045747,positive regulation of Notch signaling pathway,0.395510204
0,0.026885318,3,70,GO:0050768;GO:0010721;GO:0051961,negative regulation of nervous system development,0.396138211
0,0.027007934,3,39,GO:0043086,negative regulation of catalytic activity,0.396348884
0,0.02687063,2,149,GO:0006457,protein folding,0.396639511
0,0.027202339,3,7,GO:0000045;GO:1905037,autophagosome assembly,0.396868687
0,0.027147622,-1,6,GO:0007090,obsolete regulation of S phase of mitotic cell cycle,0.396963563
0,0.027434734,2,58,GO:0010639,negative regulation of organelle organization,0.398991935
0,0.027515379,4,13,GO:0070374;GO:0070372,regulation of ERK1 and ERK2 cascade,0.399195171
0,0.027708861,4,5,GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,0.400702811
0,0.027995172,2,6,GO:0051085;GO:0061077,chaperone-mediated protein folding,0.403907816
0,0.028757521,3,6,GO:0016189,synaptic vesicle to endosome fusion,0.405039526
0,0.028285533,4,40,GO:0006275,regulation of DNA replication,0.4055
0,0.02840212,4,24,GO:0040014,regulation of multicellular organism growth,0.405588822
0,0.028756512,2,23,GO:0050900,leukocyte migration,0.405841584
0,0.02868525,2,14,GO:0051781;GO:0051302,regulation of cell division,0.405853175
0,0.028632743,2,5,GO:0000387,spliceosomal snRNP assembly,0.405964215
0,0.028943,2,5,GO:0032365,intracellular lipid transport,0.406397638
0,0.028605616,2,56,GO:0046434,organophosphate catabolic process,0.406673307
0,0.028897675,3,146,GO:0040008,regulation of growth,0.406706114
0,0.02931911,2,47,GO:0006338,chromatin remodeling,0.407436399
0,0.029137768,4,5,GO:0048803;GO:0048805;GO:0048808;GO:0035126;GO:0090598,imaginal disc-derived male genitalia morphogenesis,0.407662083
0,0.029573758,4,37,GO:0031667;GO:0009991,response to nutrient levels,0.407879377
0,0.02930595,2,104,GO:0032989,cellular component morphogenesis,0.408137255
0,0.029535802,2,8,GO:0043388,positive regulation of DNA binding,0.4082846
0,0.029971385,2,134,GO:0006897;GO:0098657,import into cell,0.408880309
0,0.029506498,2,53,GO:0042445,hormone metabolic process,0.408886719
0,0.029955059,2,12,GO:0006739,NADP metabolic process,0.409477756
0,0.029832717,2,17,GO:0007584,response to nutrient,0.409902913
0,0.029946697,2,19,GO:0042552;GO:0008366;GO:0007272,axon ensheathment,0.410174419
0,0.030408373,2,7,GO:0072523,purine-containing compound catabolic process,0.412115385
0,0.030345966,2,99,GO:0044092,negative regulation of molecular function,0.412235067
0,0.030526115,2,14,GO:0051289,protein homotetramerization,0.412667946
0,0.031117054,4,5,GO:0009826,unidimensional cell growth,0.416921606
0,0.031113564,4,28,GO:0022904,respiratory electron transport chain,0.417720307
0,0.031651364,4,11,GO:0021515,cell differentiation in spinal cord,0.421851145
0,0.031951961,3,319,GO:0032879,regulation of localization,0.422528517
0,0.032181736,2,12,GO:0034311,diol metabolic process,0.42268431
0,0.032279926,2,6,GO:0007476;GO:0035114;GO:0035120,imaginal disc-derived appendage morphogenesis,0.422830189
0,0.031906529,3,7,GO:0006102,isocitrate metabolic process,0.423142857
0,0.032176981,3,106,GO:0008202,steroid metabolic process,0.423484848
0,0.032129738,4,27,GO:0042058;GO:1901184,regulation of epidermal growth factor receptor signaling pathway,0.423624288
0,0.032920093,2,186,GO:0051049,regulation of transport,0.427579737
0,0.032894459,2,50,GO:0022403;GO:0044848,biological phase,0.428007519
0,0.032843343,4,30,GO:0032436;GO:1901800;GO:2000060;GO:1903052;GO:1903364,positive regulation of cellular protein catabolic process,0.428060264
0,0.033482924,4,6,GO:0046146,tetrahydrobiopterin metabolic process,0.432209738
0,0.034325095,2,6,GO:0000070,mitotic sister chromatid segregation,0.440654206
0,0.034421753,3,9,GO:0043624,cellular protein complex disassembly,0.441231343
0,0.034716059,2,46,GO:0070838;GO:0072511,divalent inorganic cation transport,0.444320298
0,0.034928085,2,5,GO:0018107,peptidyl-threonine phosphorylation,0.444619666
0,0.035235409,2,242,GO:0006886,intracellular protein transport,0.44712963
0,0.035341911,2,6,GO:0007224,smoothened signaling pathway,0.447689464
0,0.03553315,4,27,GO:0071901;GO:0006469;GO:0033673;GO:0051348,negative regulation of protein kinase activity,0.448895028
0,0.035485286,4,43,GO:0062012,regulation of small molecule metabolic process,0.449446494
0,0.035708969,2,6,GO:0090342,regulation of cell aging,0.450459559
0,0.036405811,2,7,GO:0048565,digestive tract development,0.457706422
0,0.036926363,4,27,GO:0016199;GO:0016198,axon choice point recognition,0.460511883
0,0.037246606,7,23,GO:0009749;GO:0009746;GO:0034284;GO:0009743,response to carbohydrate,0.460798548
0,0.037089196,2,10,GO:0051384,response to glucocorticoid,0.460928962
0,0.037194652,2,33,GO:1901568;GO:0006690,fatty acid derivative metabolic process,0.461
0,0.036901478,2,31,GO:0055076,transition metal ion homeostasis,0.461080586
0,0.037074333,2,80,GO:0010564,regulation of cell cycle process,0.461587591
0,0.037771375,4,29,GO:0051403;GO:0031098,stress-activated MAPK cascade,0.464466546
0,0.03826841,3,5,GO:0021670,lateral ventricle development,0.467509025
0,0.038552082,2,5,GO:0060948,cardiac vascular smooth muscle cell development,0.469189189
0,0.038868755,5,5,GO:0018126,protein hydroxylation,0.47176259
0,0.039088611,5,6,GO:0051964,negative regulation of synapse assembly,0.472311828
0,0.039085079,2,288,GO:0022402,cell cycle process,0.473159785
0,0.039946066,3,18,GO:0120032;GO:0060491,regulation of cell projection assembly,0.481305903
0,0.04072674,5,6,GO:0015908,fatty acid transport,0.485460993
0,0.040829494,6,21,GO:0090100;GO:0030513,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.485575221
0,0.040688692,2,16,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.485701599
0,0.040632106,2,53,GO:0048638,regulation of developmental growth,0.486032028
0,0.04062821,4,267,GO:0045595,regulation of cell differentiation,0.486898396
0,0.040556076,3,56,GO:0044772;GO:0044770,mitotic cell cycle phase transition,0.486964286
0,0.041823455,2,12,GO:0030514,negative regulation of BMP signaling pathway,0.495671378
0,0.042272567,3,472,GO:0050793,regulation of developmental process,0.499471831
0,0.042212396,5,6,GO:0006208;GO:0046113,nucleobase catabolic process,0.5
0,0.043526984,3,5,GO:0008258,head involution,0.508669002
0,0.043851803,2,10,GO:0010508,positive regulation of autophagy,0.508813264
0,0.043788825,2,20,GO:0050680,negative regulation of epithelial cell proliferation,0.509353147
0,0.043521538,4,26,GO:0010212,response to ionizing radiation,0.509473684
0,0.043473162,3,8,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,0.510105448
0,0.04448808,2,34,GO:0051098,regulation of binding,0.513020833
0,0.044319495,4,9,GO:0072529;GO:0046135;GO:0006213,pyrimidine-containing compound catabolic process,0.51315331
0,0.044429574,2,12,GO:0070208,protein heterotrimerization,0.513391304
0,0.044856498,2,167,GO:0051093,negative regulation of developmental process,0.515511265
0,0.045104729,2,6,GO:0070207,protein homotrimerization,0.516695502
0,0.045709011,2,11,GO:0060271;GO:0044782,cilium assembly,0.517439863
0,0.045472274,6,22,GO:0045766;GO:1904018,positive regulation of angiogenesis,0.517586207
0,0.045374248,1,129,GO:0008283,cell population proliferation,0.517875648
0,0.045691471,2,41,GO:1901990;GO:1901987,regulation of mitotic cell cycle phase transition,0.518244406
0,0.047857709,3,9,GO:0071044;GO:0008334,histone mRNA metabolic process,0.537135506
0,0.047943615,3,5,GO:0001553,luteinization,0.537414384
0,0.048227404,2,6,GO:0051928,positive regulation of calcium ion transport,0.538139932
0,0.048203048,4,48,GO:0000165;GO:0023014,signal transduction by protein phosphorylation,0.538717949
0,0.049828085,2,6,GO:0071236,cellular response to antibiotic,0.543602694
0,0.04887936,4,53,GO:0001933;GO:0031400;GO:0042326;GO:0045936;GO:0010563,negative regulation of protein modification process,0.543611584
0,0.049316045,3,7,GO:0060122,inner ear receptor cell stereocilium organization,0.543898305
0,0.049439068,5,86,GO:0051259,protein complex oligomerization,0.543908629
0,0.049707152,2,28,GO:0042446,hormone biosynthetic process,0.544013491
0,0.049279144,2,18,GO:0006895,Golgi to endosome transport,0.544312394
0,0.049206071,2,13,GO:0048265;GO:0033555,multicellular organismal response to stress,0.544472789
0,0.049705006,2,28,GO:0003013,circulatory system process,0.544932432
0,0.050478596,3,5,GO:0045880,positive regulation of smoothened signaling pathway,0.549579832
0,0.050794124,1,289,GO:0051704,multi-organism process,0.551426174
0,0.05121648,2,60,GO:0002694;GO:0050865,regulation of cell activation,0.554773869
0,0.051494377,3,32,GO:0000902,cell morphogenesis,0.556605351
0,0.051732954,7,7,GO:0050771,negative regulation of axonogenesis,0.557679466
0,0.05197241,2,290,GO:0050877;GO:0003008,system process,0.559583333
0,0.052031581,6,107,GO:0030001,metal ion transport,0.559900166
0,0.052293151,2,6,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,0.560963455
0,0.052431098,1,335,GO:0022414,reproductive process,0.561111111
0,0.052905316,3,8,GO:0032735;GO:0002833,positive regulation of interleukin-12 production,0.563305785
0,0.052905316,4,8,GO:0043011;GO:0001773;GO:0097028;GO:0019886;GO:0002495;GO:0002504;GO:0070498;GO:0045084;GO:0031666,myeloid dendritic cell activation,0.563305785
0,0.053145678,4,10,GO:0051100,negative regulation of binding,0.565841584
0,0.053593233,2,10,GO:0045075;GO:0032655,regulation of interleukin-12 production,0.567927632
0,0.053461811,3,8,GO:0043277,apoptotic cell clearance,0.567957166
0,0.053868109,4,9,GO:0050690,regulation of defense response to virus by virus,0.568688525
0,0.05381298,2,11,GO:0001889,liver development,0.56954023
0,0.054195456,2,34,GO:0008543,fibroblast growth factor receptor signaling pathway,0.569885434
0,0.054499039,4,218,GO:0051726,regulation of cell cycle,0.570228385
0,0.054382597,2,11,GO:0045598,regulation of fat cell differentiation,0.570343137
0,0.05474225,4,13,GO:0042062;GO:0048790;GO:0099558;GO:1990709;GO:0007026;GO:0031111;GO:0031114;GO:0030721,regulation of microtubule depolymerization,0.571416938
0,0.055456682,4,20,GO:0000082;GO:0044843,cell cycle G1/S phase transition,0.572016129
0,0.055221109,3,8,GO:0006024;GO:0006023,glycosaminoglycan biosynthetic process,0.5726094
0,0.055424341,4,14,GO:0007391,dorsal closure,0.5726979
0,0.05510231,2,9,GO:0042773,ATP synthesis coupled electron transport,0.572727273
0,0.055701898,2,41,GO:0034728;GO:0071824,nucleosome organization,0.57310789
0,0.055401259,2,16,GO:0006367,transcription initiation from RNA polymerase II promoter,0.573300971
0,0.056261983,2,20,GO:0007254,JNK cascade,0.57336
0,0.055082866,2,7,GO:0034614,cellular response to reactive oxygen species,0.573577236
0,0.056209072,6,74,GO:0048812;GO:0120039;GO:0048858;GO:0032990,cell part morphogenesis,0.573637821
0,0.056093175,2,5,GO:0008207,C21-steroid hormone metabolic process,0.573756019
0,0.055934639,2,6,GO:0044706;GO:0007565,multi-multicellular organism process,0.57403537
0,0.056794249,3,11,GO:0045453,bone resorption,0.575319489
0,0.057390941,3,5,GO:0022029;GO:0021885,telencephalon cell migration,0.577547771
0,0.057612525,2,8,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.578139905
0,0.057759571,2,10,GO:0030718,germ-line stem cell population maintenance,0.578809524
0,0.058655088,6,6,GO:0009154;GO:0006195;GO:0009261,ribonucleotide catabolic process,0.580376766
0,0.058489499,2,13,GO:0009074,aromatic amino acid family catabolic process,0.580551181
0,0.058795767,4,7,GO:0048259,regulation of receptor-mediated endocytosis,0.580877743
0,0.058403981,4,23,GO:0050880;GO:0035150;GO:0003018,regulation of tube size,0.580993691
0,0.058337814,1,16,GO:0000003,reproduction,0.581121643
0,0.058641268,2,186,GO:0030030,cell projection organization,0.581210692
0,0.058288013,2,10,GO:0048806,genitalia development,0.581566456
0,0.058178764,2,8,GO:0030174,regulation of DNA-dependent DNA replication initiation,0.58177496
0,0.059309746,4,19,GO:0001843;GO:0060606,tube closure,0.583881064
0,0.059686635,2,8,GO:0035690,cellular response to drug,0.5865625
0,0.060252328,3,27,GO:0006662;GO:0018904,glycerol ether metabolic process,0.587791602
0,0.060736314,2,8,GO:0090257,regulation of muscle system process,0.588330757
0,0.060202669,2,8,GO:0048844,artery morphogenesis,0.588551402
0,0.060959961,3,69,GO:0006412,translation,0.588751926
0,0.06068354,2,140,GO:0048609;GO:0007276,multicellular organismal reproductive process,0.58877709
0,0.060143217,2,17,GO:0042180,cellular ketone metabolic process,0.589235569
0,0.06066586,4,47,GO:0002683,negative regulation of immune system process,0.589379845
0,0.060944934,5,10,GO:0031397;GO:1903321,negative regulation of protein ubiquitination,0.589583333
0,0.06066283,3,6,GO:0006525,arginine metabolic process,0.590295031
0,0.06151455,2,51,GO:0002237,response to molecule of bacterial origin,0.591846154
0,0.061596601,3,26,GO:0042108;GO:0042035,regulation of cytokine biosynthetic process,0.592089094
0,0.061833407,6,7,GO:0032743,positive regulation of interleukin-2 production,0.593174847
0,0.06295932,4,52,GO:0051604,protein maturation,0.597789634
0,0.062802796,2,5,GO:0009073,aromatic amino acid family biosynthetic process,0.598165138
0,0.062877261,2,17,GO:0032984,protein-containing complex disassembly,0.598167939
0,0.063247882,3,47,GO:0050678,regulation of epithelial cell proliferation,0.598173516
0,0.063515047,3,5,GO:0060535;GO:0060536,trachea cartilage morphogenesis,0.598179059
0,0.063439267,3,12,GO:0006378;GO:0043631,RNA polyadenylation,0.598328267
0,0.062778243,2,65,GO:0000956;GO:0006402;GO:0006401,RNA catabolic process,0.598774885
0,0.064363571,2,6,GO:0000389,mRNA 3'-splice site recognition,0.604772727
0,0.064507377,3,79,GO:0006644,phospholipid metabolic process,0.605446293
0,0.064786163,2,15,GO:0090329,regulation of DNA-dependent DNA replication,0.60581571
0,0.065544712,2,30,GO:0007568,aging,0.60924812
0,0.065301412,2,83,GO:0043254,regulation of protein complex assembly,0.609426848
0,0.065502249,2,272,GO:0042592,homeostatic process,0.609713855
0,0.066066549,2,8,GO:0044703,multi-organism reproductive process,0.609940209
0,0.066043723,3,10,GO:0032012,regulation of ARF protein signal transduction,0.610853293
0,0.065906642,4,6,GO:0021533,cell differentiation in hindbrain,0.61101949
0,0.065852974,4,44,GO:0050890;GO:0007611,cognition,0.611561562
0,0.068004064,2,11,GO:0046006,regulation of activated T cell proliferation,0.612114537
0,0.067784101,2,25,GO:0018108;GO:0018212,peptidyl-tyrosine phosphorylation,0.612132353
0,0.067784101,2,5,GO:0006824,cobalt ion transport,0.613033873
0,0.068263867,4,5,GO:0032023;GO:0031638,trypsinogen activation,0.613196481
0,0.067010841,2,5,GO:0018202,peptidyl-histidine modification,0.613224368
0,0.067738711,2,14,GO:0051099,positive regulation of binding,0.613421829
0,0.066965861,3,26,GO:0070507,regulation of microtubule cytoskeleton organization,0.613764881
0,0.068485592,6,17,GO:0051291,protein heterooligomerization,0.613909224
0,0.067506928,2,35,GO:0006694,steroid biosynthetic process,0.613925926
0,0.066852956,6,62,GO:0031331;GO:0009896,positive regulation of catabolic process,0.614008942
0,0.067640068,4,5,GO:0060402;GO:0060401,calcium ion transport into cytosol,0.614127219
0,0.066768183,3,14,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.614253731
0,0.06738341,3,24,GO:0042133,neurotransmitter metabolic process,0.614317507
0,0.067738313,4,98,GO:0120036,plasma membrane bounded cell projection organization,0.614327917
0,0.070591428,3,5,GO:0008015,blood circulation,0.615710187
0,0.068833411,6,9,GO:0045736;GO:1904030,negative regulation of cyclin-dependent protein kinase activity,0.616154971
0,0.069042231,3,9,GO:0002260;GO:0001776,lymphocyte homeostasis,0.616253644
0,0.069205509,2,5,GO:0018410,C-terminal protein amino acid modification,0.616302766
0,0.070519089,3,37,GO:0032496,response to lipopolysaccharide,0.616522989
0,0.069600375,6,394,GO:0045893;GO:0010628;GO:1903508;GO:1902680;GO:0010557;GO:0031328;GO:0051254;GO:0009891;GO:0045935,positive regulation of biosynthetic process,0.616763425
0,0.06944305,3,6,GO:0001974,blood vessel remodeling,0.616860465
0,0.068993342,5,21,GO:0032386,regulation of intracellular transport,0.616934307
0,0.06974361,5,19,GO:0048015;GO:0048017,inositol lipid-mediated signaling,0.617028986
0,0.070420172,2,5,GO:0034341,response to interferon-gamma,0.617122302
0,0.070114545,3,10,GO:0032438;GO:0048753,melanosome organization,0.617846821
0,0.070410859,2,177,GO:0009628,response to abiotic stimulus,0.618011527
0,0.070262055,5,7,GO:0065002;GO:0071806;GO:0044743,intracellular protein transmembrane transport,0.618253968
0,0.070035295,2,6,GO:0008637,apoptotic mitochondrial changes,0.61845152
0,0.071110606,2,6,GO:0007416,synapse assembly,0.618481375
0,0.071474425,4,7,GO:0033003,regulation of mast cell activation,0.620243205
0,0.071834701,3,11,GO:0046456,icosanoid biosynthetic process,0.621540656
0,0.071758612,2,269,GO:0048870;GO:0040011,locomotion,0.621714286
0,0.072497038,8,29,GO:0007173;GO:0038127,epidermal growth factor receptor signaling pathway,0.621985816
0,0.072857515,5,5,GO:0043486;GO:0043044,ATP-dependent chromatin remodeling,0.622489392
0,0.072411137,3,599,GO:0006996,organelle organization,0.622585227
0,0.072255058,5,67,GO:0006869,lipid transport,0.622617354
0,0.072756368,2,14,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,0.623016997
0,0.072236823,4,7,GO:0061448;GO:0060612,connective tissue development,0.623290598
0,0.073410174,2,8,GO:0009847,spore germination,0.623977433
0,0.073287186,3,7,GO:0046470,phosphatidylcholine metabolic process,0.624293785
0,0.073675329,3,10,GO:0006695;GO:0016126;GO:1902653,sterol biosynthetic process,0.624366197
0,0.073808216,2,5,GO:0033262,regulation of nuclear cell cycle DNA replication,0.62440225
0,0.075244009,3,19,GO:0050869;GO:0050864;GO:0051250;GO:0070664;GO:0002634,regulation of B cell activation,0.625486111
0,0.075187438,8,14,GO:0046329;GO:0032873;GO:0070303,negative regulation of stress-activated MAPK cascade,0.625869263
0,0.074871112,3,7,GO:0006939,smooth muscle contraction,0.625871688
0,0.075096773,2,9,GO:0048793,pronephros development,0.62597493
0,0.07448927,5,10,GO:0006265,DNA topological change,0.62640056
0,0.074829332,3,16,GO:0071407,cellular response to organic cyclic compound,0.626675978
0,0.075545104,2,35,GO:0022411,cellular component disassembly,0.626907074
0,0.07444403,4,24,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,0.626928471
0,0.074805538,3,15,GO:0032663,regulation of interleukin-2 production,0.627342657
0,0.074417514,2,19,GO:0060562,epithelial tube morphogenesis,0.62752809
0,0.075966922,-1,7,GO:0008633,obsolete activation of pro-apoptotic gene products,0.628215768
0,0.075845475,2,28,GO:0001894,tissue homeostasis,0.628531856
0,0.076391891,2,7,GO:0010821,regulation of mitochondrion organization,0.628650138
0,0.076310579,5,66,GO:0006605,protein targeting,0.628965517
0,0.076199539,4,5,GO:0019695,choline metabolic process,0.629005525
0,0.076620115,2,8,GO:0046685,response to arsenic-containing substance,0.62909216
0,0.077139001,5,12,GO:1903524;GO:1903522,regulation of blood circulation,0.629452055
0,0.077083248,2,66,GO:0090287,regulation of cellular response to growth factor stimulus,0.630178326
0,0.076933431,4,13,GO:0046128;GO:0042278;GO:0009119,ribonucleoside metabolic process,0.63021978
0,0.078034647,6,19,GO:0006309;GO:0000737;GO:0006308,DNA catabolic process,0.635430917
0,0.078655018,4,56,GO:0007596;GO:0007599;GO:0050817,blood coagulation,0.637858117
0,0.0786013,3,9,GO:0006826,iron ion transport,0.638387978
0,0.07939273,2,33,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.638565629
0,0.079186307,7,29,GO:0048814;GO:0050773,regulation of dendrite development,0.638873813
0,0.079124726,3,26,GO:0055001,muscle cell development,0.638994565
0,0.079862282,2,6,GO:0051897,positive regulation of protein kinase B signaling,0.639338731
0,0.079382977,2,5,GO:0006997,nucleus organization,0.639363144
0,0.0791103,6,9,GO:0051896,regulation of protein kinase B signaling,0.639659864
0,0.079852258,2,13,GO:0007623,circadian rhythm,0.640135135
0,0.079077009,2,5,GO:0015698,inorganic anion transport,0.640395095
0,0.080397181,6,7,GO:0070286;GO:0060285;GO:0060287;GO:0003351;GO:0003341;GO:0060286,epithelial cilium movement involved in determination of left/right asymmetry,0.641644205
0,0.080569003,2,45,GO:0007507,heart development,0.641722746
0,0.081404981,4,7,GO:0002685,regulation of leukocyte migration,0.645497312
0,0.081947057,2,16,GO:0030858,positive regulation of epithelial cell differentiation,0.648389262
0,0.082383354,3,179,GO:1901565,organonitrogen compound catabolic process,0.649062918
0,0.08236901,5,20,GO:0043467;GO:0006109,regulation of carbohydrate metabolic process,0.649731903
0,0.082784592,2,12,GO:0017004,cytochrome complex assembly,0.65
0,0.08318835,2,15,GO:0018105;GO:0018209,peptidyl-serine modification,0.651068091
0,0.084453306,4,18,GO:0046637;GO:0046634;GO:0033962;GO:0046007;GO:0042130;GO:0050672;GO:0050868;GO:0032945;GO:1903038;GO:0022408;GO:0030889;GO:0030888;GO:0002635;GO:0002823;GO:0002820;GO:0045623;GO:0043371;GO:0045622;GO:0043370;GO:0046639;GO:2000515;GO:2000514;GO:0045581;GO:0046636;GO:0045620;GO:1902106,regulation of B cell proliferation,0.658866667
0,0.084936745,3,16,GO:0006720,isoprenoid metabolic process,0.660785619
0,0.0857707,2,20,GO:0042594;GO:0031669;GO:0031668;GO:0009267,response to starvation,0.664209827
0,0.085605412,3,101,GO:0006066,alcohol metabolic process,0.664228723
0,0.085941936,6,11,GO:0009187,cyclic nucleotide metabolic process,0.664655172
0,0.086360676,2,10,GO:0016226;GO:0031163,iron-sulfur cluster assembly,0.665343915
0,0.08627122,3,7,GO:0017158,regulation of calcium ion-dependent exocytosis,0.665629139
0,0.0866905,4,5,GO:0045332;GO:0034204;GO:0097035,phospholipid translocation,0.6665786
0,0.086808882,4,9,GO:0046331;GO:0045168,cell-cell signaling involved in cell fate commitment,0.666754617
0,0.086952291,5,29,GO:0045055,regulated exocytosis,0.667061924
0,0.088323704,4,35,GO:0000086;GO:0044839,cell cycle G2/M phase transition,0.672280472
0,0.088063583,3,5,GO:0033198,response to ATP,0.672667543
0,0.08796593,2,16,GO:0051101,regulation of DNA binding,0.672763158
0,0.088226386,2,120,GO:0090066;GO:0032535,regulation of anatomical structure size,0.672965879
0,0.088692448,3,22,GO:0009100,glycoprotein metabolic process,0.673625654
0,0.089387006,2,139,GO:0045786,negative regulation of cell cycle,0.678039216
0,0.089817309,2,75,GO:0035295;GO:0060429,tube development,0.678357236
0,0.089733164,4,16,GO:0031110,regulation of microtubule polymerization or depolymerization,0.679046997
0,0.090582775,2,29,GO:0019751,polyol metabolic process,0.681705729
0,0.091143099,3,6,GO:0007619,courtship behavior,0.682684825
0,0.090955763,2,6,GO:0046500,S-adenosylmethionine metabolic process,0.683224967
0,0.091101553,3,6,GO:0007512,adult heart development,0.683376623
0,0.091642498,2,173,GO:0007049,cell cycle,0.684326425
0,0.092338713,2,6,GO:0090234;GO:0090230;GO:1902115;GO:0090169;GO:0090224,regulation of spindle organization,0.684536082
0,0.092287192,6,56,GO:0016458,gene silencing,0.685032258
0,0.0927288,6,12,GO:0015718,monocarboxylic acid transport,0.685842986
0,0.092202413,2,9,GO:0008299,isoprenoid biosynthetic process,0.685917313
0,0.092094343,3,6,GO:0051220,cytoplasmic sequestering of protein,0.686028461
0,0.094130753,6,14,GO:0032364;GO:0033483,oxygen homeostasis,0.692297818
0,0.094007662,2,26,GO:0006022,aminoglycan metabolic process,0.69248072
0,0.095880505,2,20,GO:0030330;GO:0042770,signal transduction in response to DNA damage,0.699359795
0,0.095728523,2,17,GO:1902107,positive regulation of leukocyte differentiation,0.699551282
0,0.09627242,4,10,GO:0030148,sphingolipid biosynthetic process,0.700639386
0,0.097254513,2,5,GO:0048853,forebrain morphogenesis,0.702671756
0,0.096794306,3,458,GO:0030154,cell differentiation,0.702681992
0,0.097462208,3,7,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,0.70292249
0,0.097893378,2,19,GO:0006471,protein ADP-ribosylation,0.703037975
0,0.097803232,2,21,GO:0007492,endoderm development,0.703422053
0,0.0976477,2,10,GO:0006013,mannose metabolic process,0.703489848
0,0.097243566,2,37,GO:0048588,developmental cell growth,0.703503185
0,0.09716092,2,177,GO:0051094,positive regulation of developmental process,0.703890306
0,0.098635788,2,410,GO:0010629;GO:0010605;GO:0009892,negative regulation of metabolic process,0.705562579
0,0.099246377,2,66,GO:0007050,cell cycle arrest,0.707124842
0,0.099213301,3,8,GO:0006744;GO:0006743;GO:1901663;GO:0042181,ketone biosynthetic process,0.707954545
0,0.100273887,-1,8,GO:0051436,obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,0.712153652
0,0.100804693,4,41,GO:0045926,negative regulation of growth,0.713333333
0,0.101289162,6,14,GO:1904064;GO:1904062;GO:0034767;GO:0034765;GO:0034764,positive regulation of transmembrane transport,0.714949749
0,0.102160893,5,7,GO:0051146,striated muscle cell differentiation,0.715106117
0,0.102028327,5,54,GO:0007605;GO:0050954,sensory perception of mechanical stimulus,0.715375
0,0.101982729,6,28,GO:0061041;GO:1903034,regulation of response to wounding,0.716020025
0,0.102592488,4,30,GO:0043523;GO:1901214,regulation of neuron apoptotic process,0.71627182
0,0.101688356,3,9,GO:0007269,neurotransmitter secretion,0.716499373
0,0.101942845,3,6,GO:0006020,inositol metabolic process,0.71679198
0,0.103774308,2,7,GO:0030900,forebrain development,0.720584577
0,0.103752257,3,11,GO:0110110,positive regulation of animal organ morphogenesis,0.721295143
0,0.105496174,2,20,GO:0010634,positive regulation of epithelial cell migration,0.722811344
0,0.105124648,5,46,GO:0051345,positive regulation of hydrolase activity,0.723391089
0,0.104967739,4,6,GO:0006271;GO:0022616,DNA strand elongation,0.723667906
0,0.105487419,2,104,GO:0051129,negative regulation of cellular component organization,0.723703704
0,0.104785078,4,64,GO:0045862,positive regulation of proteolysis,0.723883375
0,0.104637277,2,9,GO:0030574,collagen catabolic process,0.724161491
0,0.106044133,3,12,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,0.72432266
0,0.105470149,4,36,GO:0019221,cytokine-mediated signaling pathway,0.72447466
0,0.108272475,2,17,GO:0048639,positive regulation of developmental growth,0.728998779
0,0.108129713,3,118,GO:0009790,embryo development,0.72903423
0,0.107570011,3,111,GO:0030155,regulation of cell adhesion,0.729141104
0,0.107817819,2,40,GO:0007417,central nervous system development,0.729534314
0,0.107302347,2,16,GO:0006493,protein O-linked glycosylation,0.729581796
0,0.108048248,3,7,GO:0072080;GO:0061326;GO:0072009,nephron tubule development,0.729742962
0,0.107514696,7,31,GO:0031047,gene silencing by RNA,0.729791155
0,0.108835043,2,16,GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway,0.731097561
0,0.111294768,2,666,GO:0048869,cellular developmental process,0.742092457
0,0.111784807,5,12,GO:0032508;GO:0032392,DNA duplex unwinding,0.744228433
0,0.112744657,2,234,GO:0006811,ion transport,0.747515152
0,0.113495847,2,20,GO:0016331,morphogenesis of embryonic epithelium,0.748007246
0,0.112660762,2,5,GO:0015844,monoamine transport,0.748118932
0,0.113424369,3,37,GO:0006766,vitamin metabolic process,0.74879081
0,0.113260818,3,8,GO:0042710;GO:0000128;GO:0098630;GO:0001403;GO:0036267;GO:0070783;GO:0044182;GO:0030447;GO:0007124,aggregation of unicellular organisms,0.749031477
0,0.114184634,4,8,GO:0015669,gas transport,0.750482509
0,0.114921443,5,5,GO:0060047;GO:0003015,heart contraction,0.751141827
0,0.114719576,6,30,GO:0050679,positive regulation of epithelial cell proliferation,0.75186747
0,0.115296161,4,214,GO:0009968;GO:0010648;GO:0023057;GO:0048585,negative regulation of response to stimulus,0.751920768
0,0.114899471,3,11,GO:0009163;GO:1901659,glycosyl compound biosynthetic process,0.75198556
0,0.115692132,2,6,GO:0060113;GO:0042490,mechanoreceptor differentiation,0.752458034
0,0.116179138,2,9,GO:0042136,neurotransmitter biosynthetic process,0.753473054
0,0.116427737,2,8,GO:1903313,positive regulation of mRNA metabolic process,0.75388756
0,0.117401677,2,8,GO:0006403;GO:0008298,RNA localization,0.75422619
0,0.116915439,3,17,GO:0046467,membrane lipid biosynthetic process,0.75447494
0,0.11678484,6,22,GO:0043524;GO:1901215,negative regulation of neuron death,0.754778973
0,0.117393587,2,49,GO:1902532,negative regulation of intracellular signal transduction,0.755065554
0,0.118372624,5,5,GO:0071985,multivesicular body sorting pathway,0.75510083
0,0.117960615,10,5,GO:0035419,activation of MAPK activity involved in innate immune response,0.755529132
0,0.11911021,4,5,GO:0060763,mammary duct terminal end bud growth,0.755614657
0,0.118988217,2,10,GO:0051053,negative regulation of DNA metabolic process,0.75591716
0,0.118328132,5,12,GO:0071726;GO:0071221;GO:0071724;GO:0070339;GO:0071220;GO:0032493;GO:0042496;GO:0070340;GO:0042494;GO:0032490;GO:0098581;GO:0009595,detection of external biotic stimulus,0.755997625
0,0.119904359,3,14,GO:0030866;GO:0030865,cortical cytoskeleton organization,0.758146399
0,0.120471023,4,20,GO:0001570,vasculogenesis,0.760023585
0,0.120674214,2,10,GO:0007032,endosome organization,0.76024735
0,0.122091378,2,84,GO:0009792,embryo development ending in birth or egg hatching,0.762837046
0,0.122004609,2,363,GO:0009653,anatomical structure morphogenesis,0.763438967
0,0.121707509,2,16,GO:0048514,blood vessel morphogenesis,0.763882353
0,0.121936414,2,7,GO:0071108,protein K48-linked deubiquitination,0.764101058
0,0.122685231,2,157,GO:0007154,cell communication,0.765222482
0,0.123704818,3,10,GO:0032411;GO:0022898;GO:0032409,regulation of transmembrane transporter activity,0.768421053
0,0.124252389,2,8,GO:0097039,protein linear polyubiquitination,0.769567757
0,0.125232281,2,17,GO:0043627,response to estrogen,0.772753792
0,0.125527427,4,5,GO:0048701,embryonic cranial skeleton morphogenesis,0.773310023
0,0.129803597,6,5,GO:0006670;GO:0046519,sphingosine metabolic process,0.776255708
0,0.128773555,6,14,GO:0051258,protein polymerization,0.776291619
0,0.128615992,2,23,GO:0007160,cell-matrix adhesion,0.776609195
0,0.128016847,3,16,GO:0000216;GO:0000084;GO:0051320,S phase,0.776989619
0,0.129795136,2,40,GO:0007265,Ras protein signal transduction,0.777142857
0,0.126657881,2,14,GO:0007612,learning,0.777151163
0,0.128486942,5,6,GO:0007020,microtubule nucleation,0.777157652
0,0.129115415,2,8,GO:0010867;GO:0010866;GO:0046889,regulation of triglyceride biosynthetic process,0.777236239
0,0.127874671,3,12,GO:0000819,sister chromatid segregation,0.777367206
0,0.126898783,2,16,GO:0031018,endocrine pancreas development,0.777526132
0,0.126545993,2,161,GO:0044419,interspecies interaction between organisms,0.777532014
0,0.128444883,2,5,GO:0006434,seryl-tRNA aminoacylation,0.777937788
0,0.129785112,2,18,GO:0048762;GO:0001837,mesenchymal cell differentiation,0.777974828
0,0.127224988,2,21,GO:0071496,cellular response to external stimulus,0.778016241
0,0.127800735,3,20,GO:0006836,neurotransmitter transport,0.778092486
0,0.131275998,6,15,GO:0006261,DNA-dependent DNA replication,0.77814983
0,0.131453631,4,10,GO:0035051,cardiocyte differentiation,0.778174603
0,0.127427766,2,5,GO:0010225,response to UV-C,0.778447277
0,0.129666667,2,9,GO:0051346,negative regulation of hydrolase activity,0.778579611
0,0.131770035,8,5,GO:1903169,regulation of calcium ion transmembrane transport,0.778595696
0,0.127695514,7,50,GO:0051693;GO:0030835;GO:0030837;GO:0030834;GO:0051494;GO:1901880;GO:1902904;GO:0032272;GO:1901879;GO:0043242;GO:0031333;GO:0043244,negative regulation of cytoskeleton organization,0.778645833
0,0.130560404,2,285,GO:0010033,response to organic substance,0.778791334
0,0.131265163,4,8,GO:0033345;GO:0006530;GO:0006528;GO:0009068,asparagine metabolic process,0.779034091
0,0.13119146,3,14,GO:0007257,activation of JUN kinase activity,0.779749716
0,0.131034028,4,12,GO:0000724;GO:0000725,recombinational repair,0.779897494
0,0.132686784,3,14,GO:2000377,regulation of reactive oxygen species metabolic process,0.782522624
0,0.133689952,5,5,GO:0006029,proteoglycan metabolic process,0.786892655
0,0.133908288,4,28,GO:0006986;GO:0035966,response to topologically incorrect protein,0.787076749
0,0.134468313,3,15,GO:0042542,response to hydrogen peroxide,0.788613303
0,0.134968713,3,172,GO:1901700,response to oxygen-containing compound,0.789864865
0,0.135224363,4,37,GO:0009116;GO:1901657,nucleoside metabolic process,0.790326209
0,0.136652223,2,8,GO:0035112,genitalia morphogenesis,0.794775281
0,0.137818893,2,15,GO:0006904;GO:0140029,exocytic process,0.796580717
0,0.13938934,2,5,GO:0040015,negative regulation of multicellular organism growth,0.796607341
0,0.137692723,4,574,GO:0006508,proteolysis,0.797025814
0,0.139688793,2,72,GO:0001525,angiogenesis,0.797111111
0,0.139356941,2,14,GO:0007586,digestion,0.797494432
0,0.140072025,4,41,GO:0032886,regulation of microtubule-based process,0.797613762
0,0.139230875,2,56,GO:0050804;GO:0099177,modulation of chemical synaptic transmission,0.79793757
0,0.140367691,5,16,GO:0032103,positive regulation of response to external stimulus,0.798004435
0,0.138887069,2,6,GO:0070293;GO:0003014,renal system process,0.798547486
0,0.139225364,5,39,GO:0007229,integrin-mediated signaling pathway,0.798772321
0,0.141034837,6,22,GO:0043409,negative regulation of MAPK cascade,0.798839779
0,0.138582852,2,9,GO:0051823,regulation of synapse structural plasticity,0.798992161
0,0.14093816,2,20,GO:0006641;GO:0006639;GO:0006638,acylglycerol metabolic process,0.799336283
0,0.138857779,3,86,GO:0003002,regionalization,0.799440716
0,0.141520791,3,9,GO:0009109,coenzyme catabolic process,0.799448124
0,0.140929613,3,16,GO:0048025;GO:0033119;GO:0050686;GO:1903312,negative regulation of mRNA metabolic process,0.800166113
0,0.143624955,2,98,GO:0010243;GO:1901698,response to nitrogen compound,0.805126792
0,0.143894461,2,42,GO:0045732,positive regulation of protein catabolic process,0.80534141
0,0.144758261,2,10,GO:0006661,phosphatidylinositol biosynthetic process,0.807865787
0,0.145648351,2,26,GO:0070936,protein K48-linked ubiquitination,0.810494505
0,0.146250494,2,48,GO:0044057,regulation of system process,0.812074643
0,0.146734087,4,82,GO:0014070,response to organic cyclic compound,0.81370614
0,0.147191461,3,211,GO:0048731,system development,0.814403067
0,0.150979064,-1,7,GO:0043526,obsolete neuroprotection,0.814585576
0,0.147626174,4,46,GO:0050821;GO:0031647,regulation of protein stability,0.815098468
0,0.150870464,6,9,GO:0006369,termination of RNA polymerase II transcription,0.815301724
0,0.151374932,4,37,GO:0010632,regulation of epithelial cell migration,0.815591398
0,0.15003915,2,5,GO:0060349,bone morphogenesis,0.815746753
0,0.15082945,3,53,GO:0007015,actin filament organization,0.81574973
0,0.150645504,2,21,GO:0043902,positive regulation of multi-organism process,0.815766739
0,0.150312277,2,20,GO:0042593;GO:0033500,glucose homeostasis,0.815837838
0,0.149955889,4,10,GO:0040010;GO:0040009,regulation of growth rate,0.816305525
0,0.149855082,2,11,GO:0001944,vasculature development,0.81686551
0,0.149683459,3,5,GO:0031503,protein-containing complex localization,0.817046688
0,0.148561843,2,9,GO:0050994,regulation of lipid catabolic process,0.81715847
0,0.149670447,3,22,GO:0017157,regulation of exocytosis,0.817717391
0,0.152402056,6,43,GO:0031396;GO:1903320,regulation of protein modification by small protein conjugation or removal,0.81858217
0,0.149664571,3,32,GO:1901617,organic hydroxy compound biosynthetic process,0.818607182
0,0.149083093,3,48,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.818831878
0,0.152737149,2,6,GO:0006268,DNA unwinding involved in DNA replication,0.819045064
0,0.149633215,2,20,GO:0048705,skeletal system morphogenesis,0.819389978
0,0.149487934,2,17,GO:0043393,regulation of protein binding,0.819629226
0,0.153441125,3,5,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,0.820525188
0,0.154618201,2,41,GO:1901136,carbohydrate derivative catabolic process,0.82315508
0,0.154455498,2,5,GO:0060026,convergent extension,0.823501071
0,0.155361304,3,112,GO:0071900,regulation of protein serine/threonine kinase activity,0.823667377
0,0.157110581,2,13,GO:0030199,collagen fibril organization,0.823703704
0,0.15602587,4,6,GO:0044179;GO:0051715;GO:0031640;GO:0001906;GO:0044364,cell killing,0.823989362
0,0.155708419,2,20,GO:0051495;GO:1902905,positive regulation of cytoskeleton organization,0.824014909
0,0.15503366,2,7,GO:0019915,lipid storage,0.824038462
0,0.156937248,2,9,GO:0071320;GO:0051591,response to cAMP,0.824099576
0,0.155319345,3,133,GO:0070887,cellular response to chemical stimulus,0.824386339
0,0.15633246,2,39,GO:0048011;GO:0038179,neurotrophin TRK receptor signaling pathway,0.824388948
0,0.156583431,2,5,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.824469214
0,0.157751704,3,15,GO:0045603;GO:0045601;GO:0048708;GO:0048709;GO:0046427;GO:1904894;GO:0002052;GO:2000179;GO:2000648;GO:0007221;GO:0042246,positive regulation of endothelial cell differentiation,0.824682875
0,0.15688568,2,6,GO:0044036,cell wall macromolecule metabolic process,0.824920467
0,0.158353963,6,5,GO:0072234;GO:0072170;GO:0072243;GO:0072207,metanephric epithelium development,0.825712777
0,0.159465375,3,7,GO:0002443,leukocyte mediated immunity,0.827052632
0,0.159354327,-1,6,GO:0045768,obsolete positive regulation of anti-apoptosis,0.827608008
0,0.159354327,3,6,GO:0050923;GO:0050922,regulation of negative chemotaxis,0.827608008
0,0.160090047,7,52,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.828128286
0,0.161132963,3,25,GO:0031034;GO:0031033;GO:0010927,cellular component assembly involved in morphogenesis,0.831355042
0,0.161915692,2,32,GO:0043434;GO:1901652,response to peptide,0.832704403
0,0.161784997,2,9,GO:0045879,negative regulation of smoothened signaling pathway,0.833053515
0,0.162587043,2,41,GO:0007059,chromosome segregation,0.833420502
0,0.162572415,2,7,GO:0032007,negative regulation of TOR signaling,0.834240838
0,0.164003683,2,38,GO:0006814,sodium ion transport,0.834375
0,0.164308527,2,310,GO:0031324;GO:0051172,negative regulation of cellular metabolic process,0.834443288
0,0.163815648,3,101,GO:0000226,microtubule cytoskeleton organization,0.83451512
0,0.163342306,2,17,GO:1903531;GO:0051048,negative regulation of secretion by cell,0.834639498
0,0.163770933,3,24,GO:0032870,cellular response to hormone stimulus,0.835281837
0,0.164987304,2,17,GO:0032355,response to estradiol,0.836746362
0,0.165346045,5,7,GO:0034446,substrate adhesion-dependent cell spreading,0.836967809
0,0.166018948,2,6,GO:0006312,mitotic recombination,0.837564767
0,0.165855984,6,8,GO:0046129;GO:0042451;GO:0042455,ribonucleoside biosynthetic process,0.837759336
0,0.166683063,5,15,GO:0021953,central nervous system neuron differentiation,0.838250518
0,0.168348783,4,23,GO:0000904,cell morphogenesis involved in differentiation,0.83904321
0,0.167998122,3,10,GO:0009410,response to xenobiotic stimulus,0.839134912
0,0.168725965,3,16,GO:0055006,cardiac cell development,0.839208633
0,0.167464292,2,10,GO:0031646,positive regulation of neurological system process,0.839669421
0,0.167262385,2,7,GO:0061351,neural precursor cell proliferation,0.839813857
0,0.167993112,3,23,GO:0007179,transforming growth factor beta receptor signaling pathway,0.839948454
0,0.167844937,4,29,GO:0090276;GO:0046883,regulation of hormone secretion,0.840247678
0,0.170381598,8,25,GO:0006816,calcium ion transport,0.844250513
0,0.171110144,3,12,GO:0046425;GO:1904892,regulation of receptor signaling pathway via STAT,0.845846154
0,0.1734542,3,108,GO:0031329;GO:0009894,regulation of catabolic process,0.849744898
0,0.173190413,2,39,GO:0009952,anterior/posterior pattern specification,0.85020429
0,0.172901425,2,151,GO:0003006,developmental process involved in reproduction,0.850767656
0,0.173858369,2,39,GO:0046677,response to antibiotic,0.850815494
0,0.173162529,5,9,GO:0008154;GO:0030041,actin polymerization or depolymerization,0.851022495
0,0.172692667,2,25,GO:1902105,regulation of leukocyte differentiation,0.851127049
0,0.176860389,3,12,GO:0035282;GO:0001756,somitogenesis,0.854347826
0,0.176803555,2,173,GO:0050767;GO:0060284;GO:0051960,regulation of nervous system development,0.855111336
0,0.176640323,3,41,GO:0048608,reproductive structure development,0.855572442
0,0.176043928,2,11,GO:0007444,imaginal disc development,0.85574187
0,0.176512096,2,24,GO:0051705,multi-organism behavior,0.855780933
0,0.175846824,2,9,GO:0010623,programmed cell death involved in cell development,0.855798576
0,0.176399989,2,27,GO:0048469;GO:0021700,developmental maturation,0.856091371
0,0.178085098,2,21,GO:0050806,positive regulation of synaptic transmission,0.856155399
0,0.178645774,2,66,GO:0008203;GO:0016125;GO:1902652,sterol metabolic process,0.856193353
0,0.179663627,2,10,GO:0046580;GO:0051058,negative regulation of Ras protein signal transduction,0.856325301
0,0.175655333,2,5,GO:0030431,sleep,0.856364562
0,0.178974634,2,610,GO:0031325;GO:0009893;GO:0010604;GO:0051173,positive regulation of metabolic process,0.856539235
0,0.17845852,2,6,GO:0008643,carbohydrate transport,0.856552419
0,0.178062962,4,18,GO:0042692,muscle cell differentiation,0.856868687
0,0.179513545,3,150,GO:0044087,regulation of cellular component biogenesis,0.856884422
0,0.180837697,2,90,GO:0009725,response to hormone,0.859929789
0,0.181685095,2,40,GO:0046942;GO:0015849,carboxylic acid transport,0.862174349
0,0.181975205,2,12,GO:0033275;GO:0070252,actin-mediated cell contraction,0.862512513
0,0.182626374,3,101,GO:0055080;GO:0098771;GO:0050801,ion homeostasis,0.862737263
0,0.184862593,2,23,GO:0048477;GO:0007292,female gamete generation,0.863244048
0,0.184579736,6,13,GO:0006977;GO:0072431;GO:1902400;GO:1902402;GO:0072422;GO:1902403;GO:0072401;GO:0072413;GO:0072395;GO:0051437;GO:0006521;GO:0033238,obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,0.863306852
0,0.182582672,5,9,GO:0043966,histone H3 acetylation,0.8635
0,0.18442524,5,6,GO:0006465,signal peptide processing,0.863866799
0,0.183313129,3,13,GO:0007569,cell aging,0.864071856
0,0.18434815,3,6,GO:0006614;GO:0006613,cotranslational protein targeting to membrane,0.864477612
0,0.184165225,4,206,GO:0007167;GO:0007169,enzyme linked receptor protein signaling pathway,0.864940239
0,0.184072084,3,13,GO:0008589,regulation of smoothened signaling pathway,0.86560319
0,0.1868717,2,5,GO:0048703,embryonic viscerocranium morphogenesis,0.866567755
0,0.186820362,3,5,GO:0007530,sex determination,0.867277228
0,0.186591661,4,17,GO:0001508,action potential,0.867393459
0,0.18792713,2,7,GO:0051180;GO:0051181,cofactor transport,0.86846002
0,0.187753433,6,9,GO:0006559;GO:0006558;GO:1902222;GO:1902221;GO:0006570;GO:0006572,tyrosine metabolic process,0.868725296
0,0.188509387,2,8,GO:0003007,heart morphogenesis,0.869723866
0,0.195139447,2,23,GO:0030048,actin filament-based movement,0.870676329
0,0.191738285,5,29,GO:0006334;GO:0065004,protein-DNA complex assembly,0.87111437
0,0.189998893,2,5,GO:0060563,neuroepithelial cell differentiation,0.87114061
0,0.194990583,9,13,GO:0006879,cellular iron ion homeostasis,0.87122824
0,0.19126419,7,7,GO:0046058,cAMP metabolic process,0.871449559
0,0.191596356,2,5,GO:0019852,L-ascorbic acid metabolic process,0.871526419
0,0.193994307,4,31,GO:0000187,activation of MAPK activity,0.871601942
0,0.191018557,2,9,GO:0007566,embryo implantation,0.871617647
0,0.194825669,4,35,GO:0045927,positive regulation of growth,0.871636012
0,0.189853607,2,8,GO:0002066,columnar/cuboidal epithelial cell development,0.871653543
0,0.192369863,2,49,GO:0045765;GO:1901342,regulation of vasculature development,0.871679688
0,0.190872821,2,12,GO:0042472,inner ear morphogenesis,0.871933268
0,0.194687366,6,14,GO:0045047;GO:0072599;GO:0070972,protein targeting to ER,0.871947674
0,0.193928292,5,8,GO:0015914;GO:0015748,organophosphate ester transport,0.872011662
0,0.193476662,2,97,GO:2000145;GO:0030334,regulation of cell motility,0.872346641
0,0.189787644,2,104,GO:0007267;GO:0023052,signaling,0.872413793
0,0.193225945,4,12,GO:0051881,regulation of mitochondrial membrane potential,0.872417154
0,0.192984143,2,18,GO:0045834,positive regulation of lipid metabolic process,0.872634146
0,0.19465414,6,27,GO:0031398;GO:1903322,positive regulation of protein modification by small protein conjugation or removal,0.872744908
0,0.190872117,2,10,GO:0048749,compound eye development,0.872789784
0,0.196467933,6,5,GO:0051148,negative regulation of muscle cell differentiation,0.8731919
0,0.196467933,3,5,GO:0051150,regulation of smooth muscle cell differentiation,0.8731919
0,0.198084191,2,36,GO:0042110,T cell activation,0.876926782
0,0.200271549,2,18,GO:0070206,protein trimerization,0.880086372
0,0.200087439,5,28,GO:0006342;GO:0045814;GO:0097549;GO:0034401,chromatin organization involved in regulation of transcription,0.88054755
0,0.203927676,6,8,GO:0001523;GO:0016101;GO:0006721,diterpenoid metabolic process,0.880882353
0,0.201402334,2,18,GO:0060021,roof of mouth development,0.880909091
0,0.199976106,6,7,GO:2000178,negative regulation of neural precursor cell proliferation,0.880961538
0,0.201156517,2,10,GO:1903305,regulation of regulated secretory pathway,0.881034483
0,0.201789283,2,11,GO:0030307,positive regulation of cell growth,0.881070746
0,0.204388289,3,5,GO:0019985,translesion synthesis,0.881232227
0,0.205832388,3,6,GO:0001958;GO:0036075,replacement ossification,0.881367925
0,0.20561868,3,12,GO:0030149;GO:0046466,membrane lipid catabolic process,0.881444759
0,0.201028188,4,10,GO:0002062,chondrocyte differentiation,0.881495686
0,0.1999435,2,24,GO:0009886,post-embryonic animal morphogenesis,0.881616939
0,0.203883781,3,11,GO:0071364;GO:0070849,response to epidermal growth factor,0.881671415
0,0.205478615,6,33,GO:0043280;GO:0043281;GO:2001056;GO:2000116;GO:0052548;GO:0052547;GO:0010950;GO:0010952,regulation of endopeptidase activity,0.881899811
0,0.204979477,2,6,GO:0010039,response to iron ion,0.882102273
0,0.203814904,2,275,GO:0007010,cytoskeleton organization,0.882129278
0,0.203034787,4,49,GO:0043507;GO:0043506,regulation of JUN kinase activity,0.882411821
0,0.205387985,3,45,GO:0035148,tube formation,0.882497635
0,0.202548205,6,7,GO:0043666;GO:0010921;GO:0035304;GO:0035507,regulation of phosphoprotein phosphatase activity,0.882569245
0,0.20378175,2,178,GO:0034613;GO:0070727,cellular macromolecule localization,0.88282588
0,0.209048855,4,29,GO:0002831,regulation of response to biotic stimulus,0.882834425
0,0.203009421,2,764,GO:0065008,regulation of biological quality,0.883206107
0,0.208900677,4,11,GO:0045739;GO:2001022,positive regulation of DNA repair,0.883333333
0,0.208640623,3,328,GO:0048513,animal organ development,0.883458294
0,0.207999917,3,22,GO:0002755;GO:0034130;GO:0034134,MyD88-dependent toll-like receptor signaling pathway,0.883474178
0,0.203778575,4,5,GO:0010912;GO:0010911,positive regulation of isomerase activity,0.883619048
0,0.207827411,5,11,GO:0051489,regulation of filopodium assembly,0.883646617
0,0.206990383,2,43,GO:0016482,cytosolic transport,0.883741753
0,0.208470886,2,37,GO:0008286,insulin receptor signaling pathway,0.883818011
0,0.207657093,2,5,GO:0072347,response to anesthetic,0.883866416
0,0.209943331,2,16,GO:0060325,face morphogenesis,0.884205607
0,0.207563244,3,198,GO:0016477,cell migration,0.884322034
0,0.211612703,5,7,GO:0006270,DNA replication initiation,0.887126866
0,0.211514967,2,10,GO:0035821,modification of morphology or physiology of other organism,0.887628385
0,0.214632441,3,5,GO:0008585,female gonad development,0.888507878
0,0.215674078,2,7,GO:0090103,cochlea morphogenesis,0.889279113
0,0.214571449,4,13,GO:0007274,neuromuscular synaptic transmission,0.889332096
0,0.215543342,4,36,GO:0045665,negative regulation of neuron differentiation,0.889546716
0,0.216872975,2,144,GO:0048468,cell development,0.889723502
0,0.21453129,3,12,GO:0021782,glial cell development,0.889972145
0,0.215376419,2,6,GO:0043279,response to alkaloid,0.89
0,0.216802136,4,113,GO:0032940;GO:0046903,secretion,0.890313653
0,0.216473381,4,27,GO:0030178,negative regulation of Wnt signaling pathway,0.890350877
0,0.214470916,3,15,GO:0046847,filopodium assembly,0.890752788
0,0.217702591,4,20,GO:0050796,regulation of insulin secretion,0.891298343
0,0.214033678,2,9,GO:0001502,cartilage condensation,0.891340782
0,0.219141554,2,15,GO:0014074;GO:0046683,response to purine-containing compound,0.891697248
0,0.21392668,2,204,GO:0080134,regulation of response to stress,0.892031687
0,0.219024878,2,9,GO:0010043,response to zinc ion,0.892194674
0,0.218468828,7,71,GO:0006875;GO:0055065,metal ion homeostasis,0.892640294
0,0.218914858,3,74,GO:0009314,response to radiation,0.892922794
0,0.221084608,2,6,GO:0051771,negative regulation of nitric-oxide synthase biosynthetic process,0.893150685
0,0.220874035,6,5,GO:0048712,negative regulation of astrocyte differentiation,0.893235832
0,0.221542703,5,5,GO:0048596,embryonic camera-type eye morphogenesis,0.893476277
0,0.220817284,2,13,GO:0031100;GO:0031099,regeneration,0.893961574
0,0.220812055,4,10,GO:0031641,regulation of myelination,0.89478022
0,0.220672627,5,38,GO:0045787,positive regulation of cell cycle,0.895233731
0,0.22330526,4,29,GO:0044089,positive regulation of cellular component biogenesis,0.896451319
0,0.225258746,2,9,GO:0009954,proximal/distal pattern formation,0.896470588
0,0.22285055,2,15,GO:0009880,embryonic pattern specification,0.896536007
0,0.223084304,5,7,GO:0030279,negative regulation of ossification,0.896584699
0,0.225134221,2,20,GO:0007517;GO:0061061,muscle organ development,0.897101449
0,0.224259098,2,17,GO:0009612,response to mechanical stimulus,0.897229791
0,0.224554163,2,17,GO:0001568,blood vessel development,0.897232305
0,0.226434813,6,200,GO:0001934;GO:0031401;GO:0042327;GO:0045937;GO:0010562,positive regulation of protein modification process,0.897560976
0,0.224240388,4,13,GO:0045444,fat cell differentiation,0.898045455
0,0.226346426,2,1084,GO:0048856,anatomical structure development,0.89823689
0,0.228296602,2,35,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,0.89860486
0,0.22933039,7,5,GO:0006383,transcription by RNA polymerase III,0.89901168
0,0.227946908,2,52,GO:0031589,cell-substrate adhesion,0.899188458
0,0.228282654,2,10,GO:0070509,calcium ion import,0.899414414
0,0.229182687,2,1073,GO:0048522;GO:0048518,positive regulation of biological process,0.89955036
0,0.229774368,2,5,GO:0019377,glycolipid catabolic process,0.899640934
0,0.227755316,2,12,GO:0022008,neurogenesis,0.899684116
0,0.230609999,2,11,GO:0033344;GO:0030301;GO:0015918,cholesterol transport,0.901748879
0,0.23322618,3,26,GO:0009593,detection of chemical stimulus,0.90487042
0,0.232691659,2,119,GO:0009887,animal organ morphogenesis,0.904874776
0,0.232197282,3,6,GO:0000050;GO:0019627;GO:0071941,urea cycle,0.905286738
0,0.232587267,2,9,GO:0047496;GO:0099518;GO:0072383;GO:0072386,vesicle transport along microtubule,0.905461056
0,0.2340527,2,10,GO:0048704,embryonic skeletal system morphogenesis,0.906205357
0,0.234763101,2,20,GO:0032755;GO:0002460;GO:0002250;GO:0042088;GO:0045410;GO:0045408,positive regulation of interleukin-6 production,0.907225691
0,0.236129735,5,132,GO:0010975;GO:0045664;GO:0120035;GO:0031344,regulation of neuron differentiation,0.909714795
0,0.237166705,6,8,GO:0031295;GO:0031294,T cell costimulation,0.909866667
0,0.236967408,3,11,GO:0048563,post-embryonic animal organ morphogenesis,0.910320285
0,0.236739562,3,98,GO:0022900,electron transport chain,0.910463045
0,0.239149795,4,17,GO:0007368;GO:0009855;GO:0009799,determination of bilateral symmetry,0.914520426
0,0.240919028,4,20,GO:0043200,response to amino acid,0.917227635
0,0.240824165,4,8,GO:0060484;GO:0060485,mesenchyme development,0.917774823
0,0.240506239,1,1070,GO:0032501,multicellular organismal process,0.917879326
0,0.242315225,2,11,GO:0007585,respiratory gaseous exchange,0.918832891
0,0.242239062,6,265,GO:0045892;GO:1903507;GO:2000113;GO:1902679;GO:0010558;GO:0031327;GO:0051253;GO:0009890;GO:0045934,negative regulation of biosynthetic process,0.919380531
0,0.24348045,2,28,GO:0048562,embryonic organ morphogenesis,0.920671378
0,0.244456664,6,11,GO:0001922;GO:0001782;GO:0045779;GO:0046851;GO:0034104;GO:2000349;GO:2000348;GO:2000352;GO:1904036;GO:2000351;GO:1904035;GO:0032703;GO:0090291;GO:0090289;GO:0034136;GO:0034122;GO:0034135;GO:0034121;GO:0034140;GO:0034139;GO:0070423;GO:0002753;GO:0035872;GO:0061043;GO:0072573;GO:0002507;GO:0031665;GO:0002832,negative regulation of interleukin-2 production,0.921737213
0,0.244368184,5,11,GO:0001754;GO:0046530,photoreceptor cell differentiation,0.922374228
0,0.251528091,8,20,GO:0006885;GO:0055067,regulation of pH,0.92254987
0,0.251842906,2,33,GO:0090305,nucleic acid phosphodiester bond hydrolysis,0.922573657
0,0.25044468,3,5,GO:0035315,hair cell differentiation,0.922652174
0,0.251493645,3,5,GO:0070121,Kupffer's vesicle development,0.923263889
0,0.250399013,2,66,GO:0040017;GO:0030335;GO:2000147;GO:0051272,positive regulation of cellular component movement,0.923368146
0,0.25116864,6,5,GO:0006298,mismatch repair,0.923414422
0,0.252707431,3,101,GO:0032269;GO:0051248,negative regulation of protein metabolic process,0.923722944
0,0.250254395,3,17,GO:0046488,phosphatidylinositol metabolic process,0.923824042
0,0.249490578,2,45,GO:0061136;GO:1903050;GO:1903362;GO:0032434;GO:2000058,regulation of cellular protein catabolic process,0.92386562
0,0.245624427,4,58,GO:0007268;GO:0098916;GO:0099537;GO:0099536,trans-synaptic signaling,0.923876652
0,0.250081126,4,14,GO:0090208;GO:0090207,regulation of triglyceride metabolic process,0.924367916
0,0.24939686,4,17,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.924585153
0,0.25361897,6,11,GO:0030521,androgen receptor signaling pathway,0.924632671
0,0.246167554,6,14,GO:0006376,mRNA splice site selection,0.924691901
0,0.249135788,4,5,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,0.924737762
0,0.253432533,4,5,GO:0007406;GO:2000647,negative regulation of neuroblast proliferation,0.925086505
0,0.248467618,4,44,GO:0060249,anatomical structure homeostasis,0.925262697
0,0.248976836,7,62,GO:0006366,transcription by RNA polymerase II,0.925284339
0,0.24797524,2,11,GO:0006813,potassium ion transport,0.925701754
0,0.254505811,3,6,GO:0009311,oligosaccharide metabolic process,0.925906736
0,0.247783917,2,36,GO:0009798,axis specification,0.92594381
0,0.248387209,2,19,GO:0006282;GO:2001020,regulation of response to DNA damage stimulus,0.925985977
0,0.254868558,2,158,GO:0006812,cation transport,0.926143227
0,0.247373634,3,260,GO:0032270;GO:0051247,positive regulation of protein metabolic process,0.926737027
0,0.247768155,2,16,GO:0007608;GO:0007606,sensory perception of chemical stimulus,0.926757469
0,0.256324171,5,13,GO:0070830;GO:0120192;GO:0120193,tight junction organization,0.927347115
0,0.256023881,5,5,GO:0015809;GO:0015802,arginine transport,0.9275
0,0.256864249,2,5,GO:0048839,inner ear development,0.928012048
0,0.257500975,2,10,GO:0005513,detection of calcium ion,0.928460877
0,0.25966928,4,8,GO:0006071;GO:0019400,glycerol metabolic process,0.929580479
0,0.258897951,2,5,GO:0021508,floor plate formation,0.929914163
0,0.258618721,3,8,GO:0030263,apoptotic chromosome condensation,0.930111684
0,0.259344446,2,51,GO:0060627,regulation of vesicle-mediated transport,0.930188679
0,0.259572594,2,6,GO:0034308,primary alcohol metabolic process,0.930291345
0,0.26077724,2,6,GO:0050805,negative regulation of synaptic transmission,0.931223268
0,0.263562726,2,12,GO:0007006,mitochondrial membrane organization,0.93125
0,0.26143775,2,16,GO:0051607,defense response to virus,0.931923077
0,0.263530359,2,82,GO:0097435,supramolecular fiber organization,0.932042553
0,0.263219303,2,9,GO:0051103;GO:0006266,DNA ligation,0.932155026
0,0.262372218,2,5,GO:0001550,ovarian cumulus expansion,0.932749787
0,0.263213687,3,11,GO:0007097;GO:0051647,nucleus localization,0.932949702
0,0.262810072,5,12,GO:0044773;GO:0044774,mitotic DNA integrity checkpoint,0.933020478
0,0.264951698,5,121,GO:0045597,positive regulation of cell differentiation,0.93364486
0,0.265537254,2,18,GO:0015850,organic hydroxy compound transport,0.934125637
0,0.268426468,2,10,GO:0030323,respiratory tube development,0.939694656
0,0.269168015,2,9,GO:0015936,coenzyme A metabolic process,0.940042373
0,0.27346427,2,83,GO:0042493,response to drug,0.942087542
0,0.271837918,4,306,GO:0001932;GO:0031399;GO:0042325;GO:0019220;GO:0051174,regulation of protein modification process,0.942398649
0,0.272827608,3,20,GO:0051963,regulation of synapse assembly,0.942580101
0,0.273336383,2,15,GO:0009306;GO:0002790,peptide secretion,0.942796967
0,0.272615444,3,31,GO:0030010,establishment of cell polarity,0.942827004
0,0.271742498,2,20,GO:0050727,regulation of inflammatory response,0.943153001
0,0.271272871,2,54,GO:0043062;GO:0030198,extracellular structure organization,0.943903472
0,0.271651225,3,10,GO:0070192,chromosome organization involved in meiotic cell cycle,0.943950931
0,0.27488646,4,27,GO:0072331,signal transduction by p53 class mediator,0.944407065
0,0.276024884,3,12,GO:0006825,copper ion transport,0.946428571
0,0.279261985,2,7,GO:0006970,response to osmotic stress,0.95113255
0,0.278813085,3,51,GO:0008038;GO:0008037,cell recognition,0.951133501
0,0.280135869,4,12,GO:0009948,anterior/posterior axis specification,0.952430847
0,0.280807926,2,8,GO:0048525,negative regulation of viral process,0.952552301
0,0.280777248,3,17,GO:0071248;GO:0071241,cellular response to inorganic substance,0.95318258
0,0.282807083,3,6,GO:0060324;GO:0060123,face development,0.953669725
0,0.282649055,3,14,GO:0043954,cellular component maintenance,0.954048414
0,0.282402233,2,6,GO:0046189,phenol-containing compound biosynthetic process,0.954302423
0,0.284930182,3,6,GO:0001678,cellular glucose homeostasis,0.954401993
0,0.283795882,3,5,GO:0007159,leukocyte cell-cell adhesion,0.954496253
0,0.283613857,2,19,GO:0046916,cellular transition metal ion homeostasis,0.954958333
0,0.284875281,4,6,GO:0061640,cytoskeleton-dependent cytokinesis,0.954987531
0,0.282400826,2,5,GO:0043174,nucleoside salvage,0.955100334
0,0.284850325,7,8,GO:0008535,respiratory chain complex IV assembly,0.955615641
0,0.286265316,2,5,GO:0071260,cellular response to mechanical stimulus,0.956141079
0,0.287154659,6,6,GO:0006595;GO:0042401;GO:0009309,polyamine metabolic process,0.956296603
0,0.289912386,5,11,GO:0045446,endothelial cell differentiation,0.956347898
0,0.291590574,5,13,GO:0071158;GO:2000134;GO:1902807,negative regulation of cell cycle G1/S phase transition,0.956491372
0,0.287009098,2,8,GO:0001516;GO:0006693;GO:0046457;GO:0006636,prostaglandin metabolic process,0.956716418
0,0.289858935,2,14,GO:0010171,body morphogenesis,0.957054455
0,0.29149805,3,11,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,0.957072368
0,0.290875958,3,7,GO:0003143;GO:0001947,embryonic heart tube morphogenesis,0.957454695
0,0.291363318,3,9,GO:0050974;GO:0050982,detection of mechanical stimulus,0.957530864
0,0.288318567,2,14,GO:0045727;GO:0034250,positive regulation of cellular amide metabolic process,0.957533113
0,0.289724753,3,12,GO:0050906,detection of stimulus involved in sensory perception,0.957555739
0,0.289241157,2,146,GO:1901615,organic hydroxy compound metabolic process,0.95768595
0,0.292520081,2,96,GO:0051276,chromosome organization,0.958087028
0,0.289098846,9,5,GO:0008635,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,0.958312655
0,0.293305763,3,54,GO:0001701;GO:0043009,chordate embryonic development,0.958982773
0,0.294356808,2,13,GO:0019233,sensory perception of pain,0.96
0,0.295638596,2,6,GO:0016578,histone deubiquitination,0.962203112
0,0.297442535,3,64,GO:0030111,regulation of Wnt signaling pathway,0.962367347
0,0.296135593,1,53,GO:0048511,rhythmic process,0.962602291
0,0.297216585,2,202,GO:0051301,cell division,0.962867647
0,0.297184152,4,24,GO:0034754,cellular hormone metabolic process,0.963573181
0,0.301320745,2,86,GO:0051223;GO:0070201;GO:0090087;GO:0032880,regulation of protein localization,0.966382114
0,0.302207387,4,67,GO:0015711;GO:0006820,anion transport,0.966801948
0,0.301796927,2,9,GO:0021891,olfactory bulb interneuron development,0.966896832
0,0.300200152,2,21,GO:0006957;GO:0006956,complement activation,0.966911165
0,0.300741706,2,204,GO:0009605,response to external stimulus,0.966938111
0,0.301309615,2,21,GO:0055008;GO:0060415,muscle tissue morphogenesis,0.967127746
0,0.299866196,2,23,GO:0045669;GO:0045667;GO:0045778,regulation of osteoblast differentiation,0.967128874
0,0.304078923,4,14,GO:0090084;GO:0090083,regulation of inclusion body assembly,0.969748581
0,0.306528806,2,86,GO:0043406;GO:0043405;GO:0071902,regulation of MAP kinase activity,0.971804207
0,0.306261398,2,17,GO:0098813,nuclear chromosome segregation,0.971902834
0,0.305990581,6,37,GO:0060828,regulation of canonical Wnt signaling pathway,0.972123177
0,0.307581337,2,112,GO:0046328;GO:0032872;GO:0070302;GO:0080135,regulation of cellular response to stress,0.973080032
0,0.308249616,2,7,GO:0043525;GO:1901216,positive regulation of neuron apoptotic process,0.973424879
0,0.30955944,2,5,GO:0007214,gamma-aminobutyric acid signaling pathway,0.974818402
0,0.310863498,2,6,GO:0007632,visual behavior,0.975946817
0,0.310530724,3,5,GO:2000107;GO:2000106,regulation of leukocyte apoptotic process,0.976209677
0,0.311461348,6,5,GO:0006835,dicarboxylic acid transport,0.976529791
0,0.312042883,3,14,GO:0007369,gastrulation,0.976950925
0,0.312906212,5,7,GO:0035641;GO:0045794;GO:2000969;GO:1900451;GO:2000311;GO:1900449;GO:0099601;GO:2000463;GO:0051835;GO:0051968;GO:0097107;GO:0097106;GO:0098698;GO:0099084;GO:2000822;GO:1903365;GO:0021773;GO:0021879,positive regulation of excitatory postsynaptic potential,0.978054662
0,0.317563423,6,14,GO:0021884;GO:0021954,central nervous system neuron development,0.97812749
0,0.318033851,2,55,GO:0001819,positive regulation of cytokine production,0.978423567
0,0.328976875,2,41,GO:0032102,negative regulation of response to external stimulus,0.978822153
0,0.317105181,6,28,GO:0006893;GO:0098876;GO:0043001;GO:0061951;GO:0072659;GO:1990778,Golgi to plasma membrane transport,0.978890662
0,0.317521697,2,141,GO:0043410;GO:0043408,regulation of MAPK cascade,0.978907496
0,0.317054469,2,11,GO:0035235,ionotropic glutamate receptor signaling pathway,0.979472843
0,0.328905912,3,7,GO:0006516,glycoprotein catabolic process,0.979547229
0,0.314098102,2,9,GO:0046686,response to cadmium ion,0.979799197
0,0.328718503,2,5,GO:0061035,regulation of cartilage development,0.980039063
0,0.316964344,2,20,GO:0008333,endosome to lysosome transport,0.980095923
0,0.328618601,4,7,GO:0007095;GO:0044818;GO:0010972;GO:1902750,mitotic G2/M transition checkpoint,0.980609851
0,0.316840544,-1,6,GO:0042993,obsolete positive regulation of transcription factor import into nucleus,0.98076
0,0.315498887,2,19,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.980793905
0,0.319533773,2,15,GO:0031330;GO:0009895,negative regulation of catabolic process,0.980867144
0,0.323387776,2,6,GO:0010812,negative regulation of cell-substrate adhesion,0.981082148
0,0.320838516,4,5,GO:0010863;GO:1900274,regulation of phospholipase C activity,0.981111111
0,0.328422112,4,25,GO:0010810;GO:0001952,regulation of cell-substrate adhesion,0.981181534
0,0.328120837,4,8,GO:0034394,protein localization to cell surface,0.981245106
0,0.320469224,2,412,GO:0051128,regulation of cellular component organization,0.981334392
0,0.320172243,2,103,GO:0051493,regulation of cytoskeleton organization,0.9813593
0,0.315434679,5,31,GO:0072073,kidney epithelium development,0.981500803
0,0.316833395,2,21,GO:0008406,gonad development,0.981505204
0,0.321930993,2,8,GO:0008306,associative learning,0.981537242
0,0.327048917,3,15,GO:1905809,negative regulation of synapse organization,0.981632653
0,0.326547894,2,20,GO:0043113;GO:0051668,localization within membrane,0.981657502
0,0.327573317,3,162,GO:0019725,cellular homeostasis,0.981686275
0,0.321580687,2,11,GO:0034453,microtubule anchoring,0.981760508
0,0.316627529,2,5,GO:0045599,negative regulation of fat cell differentiation,0.981810897
0,0.323367679,2,9,GO:0033157;GO:1903827,regulation of cellular protein localization,0.981818182
0,0.323001254,3,7,GO:0009913,epidermal cell differentiation,0.981843354
0,0.328071397,3,13,GO:0071214;GO:0104004,cellular response to abiotic stimulus,0.981935737
0,0.332147343,2,17,GO:0030324,lung development,0.981984436
0,0.326440867,2,266,GO:0050790,regulation of catalytic activity,0.982154088
0,0.334049454,3,23,GO:0015893,drug transport,0.98223429
0,0.322771802,8,43,GO:0006874;GO:0055074;GO:0072503;GO:0072507,divalent inorganic cation homeostasis,0.982304038
0,0.325170394,5,18,GO:0030500;GO:0070167,regulation of biomineral tissue development,0.982452681
0,0.326273721,2,5,GO:0051597,response to methylmercury,0.98245476
0,0.332777925,2,10,GO:1901661,quinone metabolic process,0.982503888
0,0.332106376,4,91,GO:0032101,regulation of response to external stimulus,0.98267134
0,0.333981112,2,61,GO:0010769,regulation of cell morphogenesis involved in differentiation,0.982841615
0,0.324925814,3,15,GO:0007213;GO:0095500;GO:1903831,signal transduction involved in cellular response to ammonium ion,0.982951855
0,0.33190344,3,47,GO:2000027,regulation of animal organ morphogenesis,0.983008574
0,0.325616117,4,73,GO:0051336,regulation of hydrolase activity,0.983018125
0,0.326231617,2,442,GO:0007275,multicellular organism development,0.983228346
0,0.333963999,3,8,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,0.983566434
0,0.338260862,2,155,GO:0030029;GO:0030036,actin filament-based process,0.985046368
0,0.337185488,3,38,GO:0006470;GO:0016311,dephosphorylation,0.985515105
0,0.338139725,4,9,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.985614849
0,0.336859912,2,18,GO:0099643,signal release from synapse,0.985736434
0,0.338056812,2,91,GO:0051640,organelle localization,0.98622291
0,0.341956408,3,14,GO:0072384,organelle transport along microtubule,0.989429012
0,0.346823615,3,6,GO:0007431,salivary gland development,0.989471669
0,0.34358591,5,28,GO:0008063;GO:0034142,toll-like receptor 4 signaling pathway,0.990100154
0,0.341870643,2,5,GO:0008584,male gonad development,0.99011583
0,0.346806351,3,6,GO:0007062,sister chromatid cohesion,0.990229885
0,0.346645695,5,19,GO:0002695;GO:0050866,negative regulation of cell activation,0.990759202
0,0.343496461,2,30,GO:0030278,regulation of ossification,0.990824981
0,0.348699955,7,9,GO:0010518;GO:0060193,positive regulation of phospholipase activity,0.990856924
0,0.346373292,5,16,GO:0030217,T cell differentiation,0.990982348
0,0.34601729,6,8,GO:0031128;GO:1905332;GO:0090190;GO:0061213;GO:0090189;GO:0061217,regulation of mesonephros development,0.991282642
0,0.349679547,1,17,GO:0098743,cell aggregation,0.991590214
0,0.345019876,2,23,GO:0030100,regulation of endocytosis,0.991839877
0,0.345927065,2,5,GO:0006414,translational elongation,0.991929285
0,0.345713912,2,68,GO:0006887,exocytosis,0.992307692
0,0.351020897,2,6,GO:0034763;GO:0080164,negative regulation of transmembrane transport,0.993009931
0,0.354157827,2,16,GO:0032006,regulation of TOR signaling,0.994025875
0,0.355016122,2,35,GO:0009953,dorsal/ventral pattern formation,0.994448669
0,0.354065039,2,530,GO:0006928,movement of cell or subcellular component,0.994668698
0,0.353832371,3,19,GO:0008088,axo-dendritic transport,0.995198171
0,0.353765704,2,6,GO:0001541,ovarian follicle development,0.995881007
0,0.353459676,2,13,GO:0048872,homeostasis of number of cells,0.996145038
0,0.357528007,3,7,GO:0010891;GO:0010889;GO:0010898;GO:0010896;GO:0050996,positive regulation of lipid catabolic process,0.997758359
0,0.361142063,2,120,GO:0048598,embryonic morphogenesis,1
0,0.362638315,2,11,GO:0045807,positive regulation of endocytosis,1
0,0.362917047,-1,6,GO:0006200,obsolete ATP catabolic process,1
0,0.363053305,3,12,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,1
0,0.363084482,2,22,GO:0048167,regulation of synaptic plasticity,1
0,0.363841611,2,10,GO:0001736;GO:0007164,establishment of planar polarity,1
0,0.364144184,3,11,GO:0009914;GO:0046879,hormone transport,1
0,0.364463371,2,58,GO:0000910,cytokinesis,1
0,0.364959526,2,6,GO:0043101,purine-containing compound salvage,1
0,0.366275313,2,14,GO:0046620,regulation of organ growth,1
0,0.367091096,2,35,GO:0030182,neuron differentiation,1
0,0.368497127,2,12,GO:0070979,protein K11-linked ubiquitination,1
0,0.369671323,3,52,GO:0043900,regulation of multi-organism process,1
0,0.369858295,2,179,GO:0045859;GO:0043549;GO:0051338,regulation of transferase activity,1
0,0.370695615,2,6,GO:0045471,response to ethanol,1
0,0.371363015,2,54,GO:0001101,response to acid chemical,1
0,0.371381851,4,39,GO:0007041;GO:0007034,vacuolar transport,1
0,0.373393292,2,115,GO:0006417;GO:0010608;GO:0034248,posttranscriptional regulation of gene expression,1
0,0.374454727,2,40,GO:0048732,gland development,1
0,0.375150086,2,19,GO:0043094,cellular metabolic compound salvage,1
0,0.377078797,8,16,GO:0007250;GO:1901224;GO:1901222,activation of NF-kappaB-inducing kinase activity,1
0,0.377646901,3,18,GO:0006691;GO:0031408;GO:0031407,leukotriene metabolic process,1
0,0.378564617,8,5,GO:0032793,positive regulation of CREB transcription factor activity,1
0,0.379895079,4,28,GO:0090101;GO:0090288,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,0.379914006,2,26,GO:0007043;GO:0045216,cell-cell junction organization,1
0,0.380700197,5,7,GO:0006337;GO:0032986,nucleosome disassembly,1
0,0.38107121,4,36,GO:0030177,positive regulation of Wnt signaling pathway,1
0,0.381755359,2,90,GO:0051130,positive regulation of cellular component organization,1
0,0.381839639,5,84,GO:0051046;GO:1903530,regulation of secretion,1
0,0.382634185,2,11,GO:0007617;GO:0019098,reproductive behavior,1
0,0.382659989,3,10,GO:0048048,embryonic eye morphogenesis,1
0,0.385706621,2,7,GO:0017000,antibiotic biosynthetic process,1
0,0.386848979,2,108,GO:0001775,cell activation,1
0,0.387103392,3,20,GO:0045197;GO:0035088;GO:0061245,establishment or maintenance of bipolar cell polarity,1
0,0.388158,5,9,GO:0051145,smooth muscle cell differentiation,1
0,0.389719999,4,12,GO:0051893;GO:0090109;GO:1903391;GO:1901888,regulation of cell junction assembly,1
0,0.390496499,2,12,GO:0007616;GO:0007613,memory,1
0,0.390610426,3,35,GO:0008593,regulation of Notch signaling pathway,1
0,0.3911697,4,145,GO:0048878,chemical homeostasis,1
0,0.392003746,2,20,GO:0050777,negative regulation of immune response,1
0,0.392371187,2,6,GO:0001658,branching involved in ureteric bud morphogenesis,1
0,0.396325094,4,6,GO:0048096;GO:0045815,chromatin-mediated maintenance of transcription,1
0,0.396840553,2,234,GO:0006952,defense response,1
0,0.39989287,2,15,GO:0031145,anaphase-promoting complex-dependent catabolic process,1
0,0.399902505,3,51,GO:0016579;GO:0070646,protein modification by small protein removal,1
0,0.400996681,2,5,GO:0016319,mushroom body development,1
0,0.403918226,2,89,GO:1902903;GO:0110053;GO:0032956;GO:0032970,regulation of actin cytoskeleton organization,1
0,0.404050173,4,32,GO:0010970;GO:0030705;GO:0099111,cytoskeleton-dependent intracellular transport,1
0,0.405716648,4,28,GO:0006665,sphingolipid metabolic process,1
0,0.405770922,6,13,GO:0050709;GO:0002792;GO:0051224;GO:1904950,negative regulation of protein transport,1
0,0.407041282,2,9,GO:0043152,induction of bacterial agglutination,1
0,0.407306009,2,25,GO:0030308,negative regulation of cell growth,1
0,0.407501851,3,25,GO:0000077;GO:0031570,DNA integrity checkpoint,1
0,0.408058861,2,6,GO:0007131;GO:0035825,reciprocal meiotic recombination,1
0,0.408167804,4,9,GO:0031122,cytoplasmic microtubule organization,1
0,0.408172667,2,33,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,0.408601776,4,22,GO:0031532,actin cytoskeleton reorganization,1
0,0.411490831,2,13,GO:0019730;GO:0019731,antimicrobial humoral response,1
0,0.411909819,8,144,GO:0045944,positive regulation of transcription by RNA polymerase II,1
0,0.413239982,7,9,GO:0006283,transcription-coupled nucleotide-excision repair,1
0,0.413584611,2,38,GO:0050808,synapse organization,1
0,0.415124959,5,5,GO:0043271,negative regulation of ion transport,1
0,0.416862344,3,8,GO:0019884;GO:0002478,antigen processing and presentation of exogenous antigen,1
0,0.417450301,2,214,GO:0022603,regulation of anatomical structure morphogenesis,1
0,0.418871435,7,7,GO:0048008,platelet-derived growth factor receptor signaling pathway,1
0,0.418887362,3,6,GO:0034644;GO:0071482,cellular response to light stimulus,1
0,0.42055301,5,50,GO:0034220,ion transmembrane transport,1
0,0.420916948,5,62,GO:0046330;GO:0032874;GO:0070304,positive regulation of stress-activated MAPK cascade,1
0,0.421355818,3,78,GO:0007601;GO:0050953,sensory perception of light stimulus,1
0,0.422046479,5,10,GO:0006544,glycine metabolic process,1
0,0.422132032,3,5,GO:0030916,otic vesicle formation,1
0,0.422146011,2,16,GO:0001755,neural crest cell migration,1
0,0.424126999,4,7,GO:0005979;GO:0010962;GO:0070873;GO:0032885;GO:0032881,regulation of polysaccharide biosynthetic process,1
0,0.425602889,2,5,GO:0001967,suckling behavior,1
0,0.426439465,2,34,GO:0001501,skeletal system development,1
0,0.426559891,2,11,GO:0030516;GO:0061387,regulation of extent of cell growth,1
0,0.426662237,2,68,GO:0001558,regulation of cell growth,1
0,0.42681018,4,16,GO:0030203,glycosaminoglycan metabolic process,1
0,0.427039992,4,159,GO:0007600,sensory perception,1
0,0.428186687,2,26,GO:0030098,lymphocyte differentiation,1
0,0.429231795,2,14,GO:0044764,multi-organism cellular process,1
0,0.433006525,3,6,GO:0045116,protein neddylation,1
0,0.435532458,3,7,GO:1903409,reactive oxygen species biosynthetic process,1
0,0.43710874,2,346,GO:2000026,regulation of multicellular organismal development,1
0,0.438900816,2,22,GO:0007009,plasma membrane organization,1
0,0.439414719,2,9,GO:0006703,estrogen biosynthetic process,1
0,0.439480245,2,18,GO:0030326;GO:0035108,limb morphogenesis,1
0,0.441680742,7,9,GO:0048041;GO:0007045;GO:0034333,focal adhesion assembly,1
0,0.442349571,2,293,GO:0009057;GO:0044265,macromolecule catabolic process,1
0,0.443209231,4,22,GO:0002119;GO:0002164,larval development,1
0,0.443914948,3,70,GO:0050769;GO:0010720;GO:0051962,positive regulation of nervous system development,1
0,0.445931351,3,5,GO:0009101,glycoprotein biosynthetic process,1
0,0.447304643,2,32,GO:0051051,negative regulation of transport,1
0,0.447348403,2,6,GO:0030902,hindbrain development,1
0,0.447921822,3,44,GO:0008360,regulation of cell shape,1
0,0.447934202,2,12,GO:0007631,feeding behavior,1
0,0.449493702,2,60,GO:0051050,positive regulation of transport,1
0,0.451521937,2,61,GO:0046777,protein autophosphorylation,1
0,0.451728973,2,25,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1
0,0.451953891,2,11,GO:0048009,insulin-like growth factor receptor signaling pathway,1
0,0.452789526,2,105,GO:0022604,regulation of cell morphogenesis,1
0,0.453092419,2,50,GO:0051656,establishment of organelle localization,1
0,0.453915975,5,10,GO:0046532;GO:0046533,regulation of photoreceptor cell differentiation,1
0,0.455035398,5,22,GO:0031644,regulation of neurological system process,1
0,0.456271288,3,15,GO:0071156,regulation of cell cycle arrest,1
0,0.458549299,4,17,GO:0097193;GO:0097190;GO:0008630,apoptotic signaling pathway,1
0,0.458820715,5,101,GO:0006310,DNA recombination,1
0,0.459521851,2,47,GO:0042391,regulation of membrane potential,1
0,0.460071069,3,6,GO:0051930;GO:0051931,regulation of sensory perception of pain,1
0,0.460714108,3,9,GO:0006506;GO:0006505;GO:0009247,glycolipid biosynthetic process,1
0,0.460715313,2,12,GO:0045861,negative regulation of proteolysis,1
0,0.461177557,3,17,GO:0060041,retina development in camera-type eye,1
0,0.461326026,3,63,GO:0045089;GO:0031349;GO:0045088,regulation of innate immune response,1
0,0.46171365,2,18,GO:0007528,neuromuscular junction development,1
0,0.466869673,3,94,GO:0030162,regulation of proteolysis,1
0,0.466905238,2,28,GO:0048813,dendrite morphogenesis,1
0,0.467406027,4,7,GO:0060348,bone development,1
0,0.467832988,2,6,GO:0007279,pole cell formation,1
0,0.467832988,2,6,GO:0072089,stem cell proliferation,1
0,0.468488547,2,13,GO:0051205,protein insertion into membrane,1
0,0.468914441,4,5,GO:0060487;GO:0060479,lung cell differentiation,1
0,0.470753043,2,9,GO:0048190;GO:0007450;GO:0035222;GO:0007447,wing disc pattern formation,1
0,0.471042168,2,41,GO:0007409,axonogenesis,1
0,0.472432196,3,184,GO:1902533,positive regulation of intracellular signal transduction,1
0,0.472621626,2,130,GO:0009719,response to endogenous stimulus,1
0,0.472777386,2,8,GO:0006284,base-excision repair,1
0,0.474027058,3,13,GO:0034332,adherens junction organization,1
0,0.474032391,4,7,GO:0055003;GO:0030239;GO:0045214;GO:0048769;GO:0030240,myofibril assembly,1
0,0.474848972,3,14,GO:0042752,regulation of circadian rhythm,1
0,0.475245292,3,7,GO:0070997,neuron death,1
0,0.475584027,2,396,GO:0065009,regulation of molecular function,1
0,0.475610691,5,16,GO:0006672,ceramide metabolic process,1
0,0.476542199,8,14,GO:0035279;GO:0098795;GO:0006379;GO:0090501,mRNA cleavage,1
0,0.476799498,3,25,GO:0048002;GO:0019882,antigen processing and presentation,1
0,0.479183019,2,7,GO:0030838,positive regulation of actin filament polymerization,1
0,0.479760263,6,18,GO:0048169;GO:0048168,regulation of neuronal synaptic plasticity,1
0,0.479951667,2,15,GO:0008210,estrogen metabolic process,1
0,0.480444195,2,10,GO:0009583,detection of light stimulus,1
0,0.481653204,4,10,GO:0048745,smooth muscle tissue development,1
0,0.482401333,6,13,GO:0032273;GO:0031334,positive regulation of protein complex assembly,1
0,0.485147267,3,10,GO:0010389;GO:1902749,regulation of G2/M transition of mitotic cell cycle,1
0,0.485459571,2,9,GO:0046626;GO:1900076,regulation of insulin receptor signaling pathway,1
0,0.485489659,2,22,GO:0009582;GO:0009581,detection of abiotic stimulus,1
0,0.485784508,3,13,GO:0071375;GO:1901653,cellular response to peptide hormone stimulus,1
0,0.486084021,3,55,GO:0001654;GO:0007423,sensory organ development,1
0,0.486345597,2,6,GO:0021744;GO:0048857,neural nucleus development,1
0,0.486473912,4,22,GO:0006801,superoxide metabolic process,1
0,0.488603075,3,7,GO:0048145,regulation of fibroblast proliferation,1
0,0.488636079,2,24,GO:0001657;GO:0072164;GO:0072163,mesonephric tubule development,1
0,0.490685606,5,14,GO:0060346;GO:0060343;GO:0030501;GO:0070169,positive regulation of biomineral tissue development,1
0,0.491124652,2,12,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1
0,0.491493104,3,5,GO:0007016,cytoskeletal anchoring at plasma membrane,1
0,0.491718698,2,5,GO:0010002,cardioblast differentiation,1
0,0.4935924,3,18,GO:0090184;GO:0090183,regulation of kidney development,1
0,0.49418459,5,5,GO:0006654;GO:0046473,phosphatidic acid biosynthetic process,1
0,0.494503859,4,87,GO:0007219,Notch signaling pathway,1
0,0.495062838,2,8,GO:0009268,response to pH,1
0,0.49668512,4,25,GO:0051648;GO:0051650,vesicle localization,1
0,0.497743285,2,5,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1
0,0.498343394,4,13,GO:0000186,activation of MAPKK activity,1
0,0.498463404,2,7,GO:0031497,chromatin assembly,1
0,0.50059567,2,8,GO:0016332,establishment or maintenance of polarity of embryonic epithelium,1
0,0.500736865,2,57,GO:0016049,cell growth,1
0,0.501183334,5,26,GO:0023061,signal release,1
0,0.501354657,2,10,GO:0031076,embryonic camera-type eye development,1
0,0.503496027,2,51,GO:0051606,detection of stimulus,1
0,0.50363523,3,26,GO:0006865,amino acid transport,1
0,0.503823624,2,9,GO:2000736,regulation of stem cell differentiation,1
0,0.504825187,2,520,GO:0006259,DNA metabolic process,1
0,0.504922449,2,8,GO:0007440,foregut morphogenesis,1
0,0.50493656,3,30,GO:0045995,regulation of embryonic development,1
0,0.506484853,6,8,GO:0030049,muscle filament sliding,1
0,0.506830129,2,21,GO:0022602,ovulation cycle process,1
0,0.507726583,2,7,GO:0046651;GO:0032943;GO:0070661,lymphocyte proliferation,1
0,0.507841919,2,13,GO:0030183,B cell differentiation,1
0,0.510233057,4,7,GO:0032008,positive regulation of TOR signaling,1
0,0.510559617,3,12,GO:0033334,fin morphogenesis,1
0,0.511464771,5,11,GO:0016486,peptide hormone processing,1
0,0.511932815,2,7,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1
0,0.512101045,2,84,GO:0033993,response to lipid,1
0,0.512544653,3,5,GO:0045921,positive regulation of exocytosis,1
0,0.513112067,4,12,GO:0048863,stem cell differentiation,1
0,0.513719771,6,38,GO:0050770,regulation of axonogenesis,1
0,0.514013677,2,20,GO:0031424,keratinization,1
0,0.515402038,2,6,GO:0006002,fructose 6-phosphate metabolic process,1
0,0.515805483,2,14,GO:0060688,regulation of morphogenesis of a branching structure,1
0,0.515983373,2,11,GO:0033559;GO:0006692,unsaturated fatty acid metabolic process,1
0,0.516719405,3,8,GO:0000018,regulation of DNA recombination,1
0,0.51757359,2,11,GO:0035303,regulation of dephosphorylation,1
0,0.517675679,3,69,GO:0046649;GO:0045321,leukocyte activation,1
0,0.518580604,4,18,GO:0006664;GO:1903509,liposaccharide metabolic process,1
0,0.521040786,2,18,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,1
0,0.521663994,3,8,GO:0050766;GO:0050764,regulation of phagocytosis,1
0,0.524112458,2,23,GO:0090068,positive regulation of cell cycle process,1
0,0.524151293,2,805,GO:0009966;GO:0010646;GO:0023051;GO:0048583,regulation of response to stimulus,1
0,0.526024363,2,8,GO:0009950,dorsal/ventral axis specification,1
0,0.527083891,3,38,GO:0007281,germ cell development,1
0,0.527533763,3,23,GO:0009411,response to UV,1
0,0.530628585,2,5,GO:0001649,osteoblast differentiation,1
0,0.530640902,2,12,GO:0048663,neuron fate commitment,1
0,0.531288842,6,17,GO:0030336;GO:2000146;GO:0051271,negative regulation of cellular component movement,1
0,0.532375666,3,6,GO:0007602,phototransduction,1
0,0.532963293,2,10,GO:0048706,embryonic skeletal system development,1
0,0.533167464,4,32,GO:0007162,negative regulation of cell adhesion,1
0,0.534045019,3,18,GO:0010771;GO:0010977;GO:0031345,negative regulation of neuron projection development,1
0,0.534220581,2,246,GO:0048646,anatomical structure formation involved in morphogenesis,1
0,0.534527879,2,13,GO:0048739;GO:0048747;GO:0055013,muscle fiber development,1
0,0.534532787,4,12,GO:0002708;GO:0002705;GO:0002706,regulation of lymphocyte mediated immunity,1
0,0.534753793,4,9,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,1
0,0.538049592,2,7,GO:0021766,hippocampus development,1
0,0.538479289,3,8,GO:0016334,establishment or maintenance of polarity of follicular epithelium,1
0,0.539363083,4,5,GO:0031623,receptor internalization,1
0,0.540246339,2,8,GO:0042359;GO:0006775,fat-soluble vitamin metabolic process,1
0,0.540967735,3,9,GO:0010454,negative regulation of cell fate commitment,1
0,0.541794916,2,46,GO:0034976,response to endoplasmic reticulum stress,1
0,0.542180156,6,5,GO:0060048,cardiac muscle contraction,1
0,0.542939203,2,18,GO:0002053;GO:0010464,regulation of mesenchymal cell proliferation,1
0,0.543497901,4,18,GO:0030241;GO:0071688,striated muscle myosin thick filament assembly,1
0,0.547525668,2,16,GO:0035162,embryonic hemopoiesis,1
0,0.547553454,2,19,GO:0040013,negative regulation of locomotion,1
0,0.547777904,2,5,GO:0032968;GO:0034243,positive regulation of transcription elongation from RNA polymerase II promoter,1
0,0.549473499,2,131,GO:0007389,pattern specification process,1
0,0.549890523,5,10,GO:0048738,cardiac muscle tissue development,1
0,0.550353867,5,6,GO:0090277;GO:0046887,positive regulation of peptide hormone secretion,1
0,0.55110523,2,26,GO:0061138;GO:0001763;GO:0048754,morphogenesis of a branching epithelium,1
0,0.553682794,4,15,GO:0007215,glutamate receptor signaling pathway,1
0,0.55512366,2,49,GO:0002252,immune effector process,1
0,0.555689509,4,17,GO:0048489;GO:0097479;GO:0097480;GO:0099003,vesicle-mediated transport in synapse,1
0,0.555823325,2,5,GO:0045910,negative regulation of DNA recombination,1
0,0.555823325,4,5,GO:2000242,negative regulation of reproductive process,1
0,0.555970191,2,14,GO:0048854,brain morphogenesis,1
0,0.556466967,3,8,GO:0009409,response to cold,1
0,0.557088099,5,82,GO:0031347,regulation of defense response,1
0,0.560287383,5,11,GO:0002065,columnar/cuboidal epithelial cell differentiation,1
0,0.560595958,6,10,GO:0019509;GO:0071267;GO:0043102;GO:0071265,L-methionine salvage,1
0,0.561201758,2,467,GO:0032268;GO:0051246,regulation of protein metabolic process,1
0,0.561357347,3,9,GO:0001778,plasma membrane repair,1
0,0.561765509,2,14,GO:0031572,G2 DNA damage checkpoint,1
0,0.563021421,2,20,GO:0032507;GO:0051651,maintenance of location in cell,1
0,0.564060284,2,36,GO:0016485,protein processing,1
0,0.564657425,2,5,GO:0021587,cerebellum morphogenesis,1
0,0.564657425,2,5,GO:0021794,thalamus development,1
0,0.564740186,2,5,GO:0070918;GO:0031050,production of small RNA involved in gene silencing by RNA,1
0,0.566079282,3,29,GO:0032675,regulation of interleukin-6 production,1
0,0.566475075,4,8,GO:0021952;GO:0021955,central nervous system projection neuron axonogenesis,1
0,0.566933381,2,8,GO:0035640,exploration behavior,1
0,0.566983476,2,14,GO:0055002,striated muscle cell development,1
0,0.568015291,2,48,GO:0042742;GO:0009617,response to bacterium,1
0,0.571856038,6,8,GO:0055081,anion homeostasis,1
0,0.572954311,2,8,GO:0035265,organ growth,1
0,0.572956291,2,34,GO:0048666,neuron development,1
0,0.57349125,2,5,GO:0003148,outflow tract septum morphogenesis,1
0,0.574388381,2,13,GO:0097305,response to alcohol,1
0,0.574664566,2,7,GO:0007212,dopamine receptor signaling pathway,1
0,0.57474344,3,22,GO:0030011,maintenance of cell polarity,1
0,0.575454053,2,203,GO:0051241,negative regulation of multicellular organismal process,1
0,0.575944752,3,5,GO:0040019,positive regulation of embryonic development,1
0,0.576623247,2,234,GO:0043085;GO:0044093,positive regulation of molecular function,1
0,0.577099237,4,20,GO:0031032,actomyosin structure organization,1
0,0.577441321,2,17,GO:0002756;GO:0034138,toll-like receptor 3 signaling pathway,1
0,0.577463873,3,9,GO:0045198;GO:0030859;GO:0035089;GO:0061162;GO:0061339,polarized epithelial cell differentiation,1
0,0.579326373,2,5,GO:0043392,negative regulation of DNA binding,1
0,0.579629431,2,5,GO:0031952,regulation of protein autophosphorylation,1
0,0.581418535,6,23,GO:0006612,protein targeting to membrane,1
0,0.582470453,2,8,GO:0008347,glial cell migration,1
0,0.583777726,2,19,GO:0051216,cartilage development,1
0,0.583872131,2,9,GO:0018149,peptide cross-linking,1
0,0.584311429,2,51,GO:0045185;GO:0051235,maintenance of location,1
0,0.584466091,4,21,GO:0035113,embryonic appendage morphogenesis,1
0,0.584559463,2,40,GO:0035107,appendage morphogenesis,1
0,0.58530252,2,25,GO:0045022;GO:0098927,early endosome to late endosome transport,1
0,0.586954153,2,383,GO:0009967;GO:0010647;GO:0023056;GO:0048584,positive regulation of response to stimulus,1
0,0.588317884,2,12,GO:0006333,chromatin assembly or disassembly,1
0,0.588625768,2,43,GO:0009416,response to light stimulus,1
0,0.588832223,2,15,GO:0090162,establishment of epithelial cell polarity,1
0,0.590203935,4,5,GO:0043552;GO:0043551;GO:0090218;GO:1903727;GO:0043550;GO:1903725,regulation of lipid kinase activity,1
0,0.593245777,2,15,GO:0061001;GO:0060998;GO:0099175,regulation of dendritic spine development,1
0,0.594016836,4,16,GO:0009395,phospholipid catabolic process,1
0,0.595774296,2,6,GO:0006622;GO:0061462,protein targeting to lysosome,1
0,0.597683762,4,68,GO:0030833;GO:0008064;GO:0032271;GO:0030832,regulation of actin filament length,1
0,0.601500954,3,44,GO:0071103,DNA conformation change,1
0,0.605563934,3,9,GO:0040001;GO:0051293;GO:0051653,spindle localization,1
0,0.607351725,2,20,GO:0048592;GO:0090596,sensory organ morphogenesis,1
0,0.607966095,6,8,GO:0010591;GO:1902743,regulation of lamellipodium organization,1
0,0.60830336,3,5,GO:0060351,cartilage development involved in endochondral bone morphogenesis,1
0,0.608412722,4,6,GO:0007413;GO:0106030,axonal fasciculation,1
0,0.6088066,2,70,GO:0032147,activation of protein kinase activity,1
0,0.610478879,2,42,GO:0060560,developmental growth involved in morphogenesis,1
0,0.610808098,2,35,GO:0060070,canonical Wnt signaling pathway,1
0,0.611611725,4,6,GO:0030072;GO:0030073,peptide hormone secretion,1
0,0.612372208,2,8,GO:0050673,epithelial cell proliferation,1
0,0.613349483,1,120,GO:0040007,growth,1
0,0.613580665,2,14,GO:0002703,regulation of leukocyte mediated immunity,1
0,0.613708163,2,38,GO:0006906;GO:0090174;GO:0048284;GO:0061025,organelle fusion,1
0,0.61449426,2,83,GO:0048589,developmental growth,1
0,0.615450637,2,10,GO:0048662,negative regulation of smooth muscle cell proliferation,1
0,0.616059323,5,9,GO:0110111,negative regulation of animal organ morphogenesis,1
0,0.617545461,5,5,GO:0019374,galactolipid metabolic process,1
0,0.617570829,2,27,GO:0001816,cytokine production,1
0,0.619677694,2,67,GO:0042176,regulation of protein catabolic process,1
0,0.620984735,3,11,GO:0010675;GO:0010906;GO:0043255,regulation of glucose metabolic process,1
0,0.622858103,2,8,GO:2001259;GO:2001257;GO:0032414;GO:0032412,regulation of cation channel activity,1
0,0.623119522,2,12,GO:0015986;GO:0015985,ATP synthesis coupled proton transport,1
0,0.623725633,2,77,GO:0007156;GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1
0,0.62492225,3,39,GO:0006643,membrane lipid metabolic process,1
0,0.626630466,4,38,GO:0002521,leukocyte differentiation,1
0,0.627302664,-1,10,GO:0035121,obsolete tail morphogenesis,1
0,0.627879807,3,20,GO:0071219;GO:0071216,cellular response to biotic stimulus,1
0,0.628118132,3,8,GO:0032374;GO:0032371;GO:0032368,regulation of lipid transport,1
0,0.628753425,2,5,GO:0048485,sympathetic nervous system development,1
0,0.634113263,2,17,GO:0043901,negative regulation of multi-organism process,1
0,0.635256569,3,11,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1
0,0.637253863,3,7,GO:0048208,COPII vesicle coating,1
0,0.637366066,3,36,GO:0006959,humoral immune response,1
0,0.638441574,3,80,GO:0015672,monovalent inorganic cation transport,1
0,0.63938807,2,5,GO:0046184,aldehyde biosynthetic process,1
0,0.640744342,4,6,GO:0007035;GO:0051452;GO:0045851,vacuolar acidification,1
0,0.641272806,2,8,GO:0060052,neurofilament cytoskeleton organization,1
0,0.641498739,7,25,GO:0015991;GO:0015988;GO:0099131;GO:0099132;GO:0090662,ATP hydrolysis coupled proton transport,1
0,0.642072604,3,14,GO:2000241,regulation of reproductive process,1
0,0.642137727,9,9,GO:0061002;GO:0050774;GO:0061000;GO:2000171,negative regulation of dendritic spine development,1
0,0.643018111,2,17,GO:0006289,nucleotide-excision repair,1
0,0.643270814,2,11,GO:0048484;GO:0042551,neuron maturation,1
0,0.643948533,3,8,GO:0071479;GO:0071478,cellular response to radiation,1
0,0.64445613,6,12,GO:0072300;GO:0072216;GO:0072298;GO:0090193;GO:0072215;GO:0090192,regulation of glomerulus development,1
0,0.646285345,2,19,GO:0001656,metanephros development,1
0,0.646604821,5,13,GO:0031290,retinal ganglion cell axon guidance,1
0,0.646806243,2,15,GO:0010517;GO:0060191,regulation of lipase activity,1
0,0.647242937,2,5,GO:0016445;GO:0002200,somatic diversification of immunoglobulins,1
0,0.647515387,5,15,GO:0048660,regulation of smooth muscle cell proliferation,1
0,0.648465435,3,6,GO:0040020;GO:0051445,regulation of meiotic nuclear division,1
0,0.650784294,2,239,GO:0051240,positive regulation of multicellular organismal process,1
0,0.650958528,5,45,GO:0050807,regulation of synapse organization,1
0,0.651441873,4,154,GO:0002684,positive regulation of immune system process,1
0,0.652680564,6,9,GO:0060045;GO:0055023;GO:0060043;GO:0055021;GO:0055025;GO:0060421;GO:0055024;GO:0060420;GO:0045844;GO:0048636;GO:1901863,positive regulation of striated muscle tissue development,1
0,0.653486199,3,6,GO:0046627;GO:1900077,negative regulation of insulin receptor signaling pathway,1
0,0.653912276,2,14,GO:0019722,calcium-mediated signaling,1
0,0.654375887,2,9,GO:0072595,maintenance of protein localization in organelle,1
0,0.656069394,2,11,GO:0006901,vesicle coating,1
0,0.657310244,2,14,GO:0071230,cellular response to amino acid stimulus,1
0,0.658771962,2,6,GO:0060059,embryonic retina morphogenesis in camera-type eye,1
0,0.659477789,7,15,GO:0001751;GO:0045314;GO:0042478;GO:0110116;GO:0007474;GO:0045610;GO:0009608;GO:0042676;GO:0046667;GO:0046666;GO:0007451;GO:0035161;GO:0035165;GO:0035163;GO:0042688;GO:0042386;GO:0035153;GO:0035214;GO:0030708;GO:0048139;GO:0048138;GO:0007403;GO:0035172;GO:0007446;GO:0008587;GO:0035171;GO:0035168;GO:0042387;GO:0007478;GO:0007560;GO:0035111;GO:0035170;GO:0007521;GO:0045316;GO:0042480;GO:0110118;GO:0035157;GO:0009996;GO:0035155;GO:0007314;GO:0007309;GO:0030720;GO:0051674;GO:0030713;GO:0045750;GO:0048052;GO:0007464;GO:0001752;GO:0042706;GO:0046552;GO:0045466;GO:0045463;GO:0007460;GO:0042686;GO:0051890;GO:2000043;GO:1905207;GO:0042689;GO:0045468;GO:0016330;GO:0007419;GO:0007473;GO:0007449,compound eye photoreceptor fate commitment,1
0,0.661941819,2,142,GO:0009888,tissue development,1
0,0.66304932,3,14,GO:0007076,mitotic chromosome condensation,1
0,0.663403679,4,15,GO:0000723;GO:0032200,telomere maintenance,1
0,0.664162363,4,12,GO:0008045,motor neuron axon guidance,1
0,0.66907817,5,6,GO:0048384,retinoic acid receptor signaling pathway,1
0,0.669611427,3,9,GO:0042987;GO:0042982,amyloid precursor protein metabolic process,1
0,0.669611427,5,9,GO:0050435,amyloid-beta metabolic process,1
0,0.669869061,2,37,GO:0048568,embryonic organ development,1
0,0.670878997,4,25,GO:0030261;GO:0006323,DNA packaging,1
0,0.671514484,2,35,GO:0018958,phenol-containing compound metabolic process,1
0,0.672630564,3,39,GO:0071417;GO:1901699,cellular response to organonitrogen compound,1
0,0.673500789,4,61,GO:0001667,ameboidal-type cell migration,1
0,0.675130248,2,111,GO:0007163,establishment or maintenance of cell polarity,1
0,0.676229013,2,13,GO:0031214,biomineral tissue development,1
0,0.679567095,3,53,GO:0050708;GO:0002791,regulation of peptide secretion,1
0,0.68011764,4,15,GO:2000045;GO:1902806,regulation of cell cycle G1/S phase transition,1
0,0.685001117,3,508,GO:0051239,regulation of multicellular organismal process,1
0,0.68548079,4,131,GO:0051270;GO:0040012,regulation of locomotion,1
0,0.689724156,2,139,GO:0046578;GO:0051056,regulation of small GTPase mediated signal transduction,1
0,0.693435301,3,7,GO:0048635,negative regulation of muscle organ development,1
0,0.693846382,3,141,GO:0043207;GO:0009607,response to biotic stimulus,1
0,0.694988254,3,16,GO:0007249,I-kappaB kinase/NF-kappaB signaling,1
0,0.695473782,2,14,GO:0010453,regulation of cell fate commitment,1
0,0.697196764,5,6,GO:0015701,bicarbonate transport,1
0,0.697978418,2,9,GO:0048013,ephrin receptor signaling pathway,1
0,0.698273987,2,98,GO:0071310,cellular response to organic substance,1
0,0.69878041,3,12,GO:0021987,cerebral cortex development,1
0,0.698972714,2,19,GO:0002699,positive regulation of immune effector process,1
0,0.699755616,3,71,GO:0035023,regulation of Rho protein signal transduction,1
0,0.700995335,3,6,GO:0008615;GO:0008614;GO:0042819;GO:0042816,vitamin B6 biosynthetic process,1
0,0.70145125,5,14,GO:0019933;GO:0019935,cyclic-nucleotide-mediated signaling,1
0,0.703329108,2,10,GO:0031023,microtubule organizing center organization,1
0,0.703408072,2,24,GO:0051047;GO:1903532,positive regulation of secretion,1
0,0.703952681,3,8,GO:0042157,lipoprotein metabolic process,1
0,0.704610773,3,24,GO:0042475;GO:0042476,odontogenesis,1
0,0.704811264,2,12,GO:0043542,endothelial cell migration,1
0,0.705537057,3,5,GO:0007362,terminal region determination,1
0,0.711801424,3,9,GO:0048264;GO:0035143;GO:0035141,determination of ventral identity,1
0,0.711878694,3,57,GO:0098542,defense response to other organism,1
0,0.712257089,4,41,GO:1902600;GO:0098660;GO:0098662;GO:0098655,inorganic ion transmembrane transport,1
0,0.713828178,2,22,GO:1905330,regulation of morphogenesis of an epithelium,1
0,0.714532432,6,161,GO:0016055;GO:1905114,Wnt signaling pathway,1
0,0.714943228,4,12,GO:0042462;GO:0042461,photoreceptor cell development,1
0,0.714963386,5,21,GO:0030433;GO:0036503,ubiquitin-dependent ERAD pathway,1
0,0.71556046,2,61,GO:0071495,cellular response to endogenous stimulus,1
0,0.716049681,2,84,GO:0001817,regulation of cytokine production,1
0,0.716113429,4,18,GO:0051222;GO:1904951;GO:0050714;GO:0002793,positive regulation of establishment of protein localization,1
0,0.720278535,4,7,GO:0007398,ectoderm development,1
0,0.720278535,2,7,GO:0046843,dorsal appendage formation,1
0,0.721294016,2,61,GO:0002697,regulation of immune effector process,1
0,0.724397054,3,49,GO:0009615,response to virus,1
0,0.724488695,2,6,GO:0045132,meiotic chromosome segregation,1
0,0.725005661,3,9,GO:0007548,sex differentiation,1
0,0.729338938,6,16,GO:0009164;GO:0034656;GO:1901658,nucleoside catabolic process,1
0,0.729574772,6,14,GO:0051453;GO:0030641;GO:0030004,regulation of cellular pH,1
0,0.729853747,2,69,GO:0043123;GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1
0,0.730676382,2,60,GO:0034329;GO:0034330,cell junction organization,1
0,0.73154234,2,165,GO:0006511;GO:0019941;GO:0051603;GO:0043632,proteolysis involved in cellular protein catabolic process,1
0,0.732678459,2,5,GO:0010259,multicellular organism aging,1
0,0.733378245,2,9,GO:0098815;GO:0071625,modulation of excitatory postsynaptic potential,1
0,0.73495594,3,7,GO:0006878;GO:0055070,copper ion homeostasis,1
0,0.735386647,3,9,GO:0006623;GO:0072666;GO:0072665,protein localization to vacuole,1
0,0.736053834,2,16,GO:0007498,mesoderm development,1
0,0.738119943,3,32,GO:0017148;GO:0034249,negative regulation of translation,1
0,0.738562581,2,7,GO:1901654,response to ketone,1
0,0.738847289,2,12,GO:0017156;GO:0016079,calcium ion regulated exocytosis,1
0,0.739484972,3,7,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1
0,0.739637964,2,7,GO:0042474;GO:0042473,middle ear morphogenesis,1
0,0.739637964,2,7,GO:0060411,cardiac septum morphogenesis,1
0,0.739935296,2,13,GO:0016925,protein sumoylation,1
0,0.741497346,4,49,GO:0051091,positive regulation of DNA-binding transcription factor activity,1
0,0.743306555,2,100,GO:0051707,response to other organism,1
0,0.745604568,3,25,GO:0001708,cell fate specification,1
0,0.747731107,2,7,GO:0098930,axonal transport,1
0,0.747895632,2,7,GO:0008293,torso signaling pathway,1
0,0.750160161,2,26,GO:0050920,regulation of chemotaxis,1
0,0.750175732,3,7,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,1
0,0.756139551,4,5,GO:0006582,melanin metabolic process,1
0,0.756436884,2,50,GO:0090150,establishment of protein localization to membrane,1
0,0.756921961,3,32,GO:0045165,cell fate commitment,1
0,0.758040353,2,25,GO:0072175;GO:0001838,epithelial tube formation,1
0,0.758838099,2,494,GO:0035556,intracellular signal transduction,1
0,0.759295749,2,67,GO:1901701,cellular response to oxygen-containing compound,1
0,0.759749967,3,15,GO:0008356,asymmetric cell division,1
0,0.760050658,3,34,GO:0009408;GO:0009266,response to temperature stimulus,1
0,0.76014702,2,7,GO:0006833;GO:0042044,fluid transport,1
0,0.762024684,3,11,GO:0007519,skeletal muscle tissue development,1
0,0.763580715,5,10,GO:0050707,regulation of cytokine secretion,1
0,0.764575514,2,5,GO:0030325,adrenal gland development,1
0,0.766023372,5,363,GO:1902531,regulation of intracellular signal transduction,1
0,0.766992981,2,41,GO:0001503,ossification,1
0,0.769589115,3,8,GO:0000278,mitotic cell cycle,1
0,0.769589115,2,8,GO:0042051,compound eye photoreceptor development,1
0,0.769589115,6,8,GO:0042659,regulation of cell fate specification,1
0,0.771668528,3,7,GO:0051965,positive regulation of synapse assembly,1
0,0.773038097,3,10,GO:0042177,negative regulation of protein catabolic process,1
0,0.773740702,5,24,GO:0006584;GO:0009712,catecholamine metabolic process,1
0,0.778513497,4,29,GO:0019932,second-messenger-mediated signaling,1
0,0.781938561,2,28,GO:0014706;GO:0060537,muscle tissue development,1
0,0.783519732,7,67,GO:0043161;GO:0010498,proteasome-mediated ubiquitin-dependent protein catabolic process,1
0,0.785557174,3,118,GO:0051090,regulation of DNA-binding transcription factor activity,1
0,0.78599658,2,48,GO:0031175,neuron projection development,1
0,0.787021692,2,119,GO:0022412,cellular process involved in reproduction in multicellular organism,1
0,0.791592497,2,81,GO:0030003;GO:0006873;GO:0055082,cellular chemical homeostasis,1
0,0.792917038,2,16,GO:0007298;GO:0007297,border follicle cell migration,1
0,0.793308622,3,15,GO:0007266,Rho protein signal transduction,1
0,0.794025122,5,7,GO:0062014,negative regulation of small molecule metabolic process,1
0,0.796375724,3,17,GO:0016202;GO:0048634;GO:1901861,regulation of muscle organ development,1
0,0.797199717,2,23,GO:0045162;GO:0045161,neuronal ion channel clustering,1
0,0.799988007,5,5,GO:0085020,protein K6-linked ubiquitination,1
0,0.801473324,5,17,GO:0006941,striated muscle contraction,1
0,0.804251937,2,9,GO:0008407,chaeta morphogenesis,1
0,0.806387226,2,15,GO:0009405,pathogenesis,1
0,0.80657762,4,32,GO:0048278;GO:0140056;GO:0022406,membrane docking,1
0,0.806947659,2,19,GO:0071695,anatomical structure maturation,1
0,0.808451783,4,46,GO:0002224;GO:0002221;GO:0002758;GO:0002218,activation of innate immune response,1
0,0.808639826,2,181,GO:0006278;GO:0071897,DNA biosynthetic process,1
0,0.808654101,5,15,GO:0071363;GO:0070848,cellular response to growth factor stimulus,1
0,0.810168013,2,5,GO:0071277,cellular response to calcium ion,1
0,0.810478602,3,7,GO:0048536,spleen development,1
0,0.810965633,2,7,GO:0050715,positive regulation of cytokine secretion,1
0,0.811910523,2,15,GO:0042060,wound healing,1
0,0.813077663,8,14,GO:0031054,pre-miRNA processing,1
0,0.814977365,3,8,GO:0006111;GO:0010677;GO:0045912,negative regulation of cellular carbohydrate metabolic process,1
0,0.817826563,4,6,GO:0070593,dendrite self-avoidance,1
0,0.817995829,4,48,GO:0051865,protein autoubiquitination,1
0,0.818724061,3,28,GO:0050852;GO:0050851;GO:0002429;GO:0002768,immune response-regulating cell surface receptor signaling pathway,1
0,0.818986059,4,8,GO:0071816;GO:0045048,protein insertion into ER membrane,1
0,0.820303021,2,94,GO:0098609,cell-cell adhesion,1
0,0.822053151,4,46,GO:0045666;GO:0010976;GO:0031346,positive regulation of neuron differentiation,1
0,0.822582212,2,9,GO:0019835,cytolysis,1
0,0.822600269,3,213,GO:0002682,regulation of immune system process,1
0,0.823480219,4,127,GO:0007186,G protein-coupled receptor signaling pathway,1
0,0.82639947,6,7,GO:0002067,glandular epithelial cell differentiation,1
0,0.82659713,2,58,GO:0007218,neuropeptide signaling pathway,1
0,0.827823357,2,6,GO:0006903,vesicle targeting,1
0,0.828077417,2,17,GO:0007635,chemosensory behavior,1
0,0.828747796,2,10,GO:0008354,germ cell migration,1
0,0.82896024,3,11,GO:0042364;GO:0009110,water-soluble vitamin biosynthetic process,1
0,0.829039266,5,40,GO:0006446,regulation of translational initiation,1
0,0.829107722,2,30,GO:0010631,epithelial cell migration,1
0,0.82943495,3,6,GO:0002366;GO:0002263;GO:0002285,cell activation involved in immune response,1
0,0.82943495,3,6,GO:0048251;GO:0085029,elastic fiber assembly,1
0,0.82943495,2,6,GO:0048286,lung alveolus development,1
0,0.829726302,3,6,GO:0051457,maintenance of protein location in nucleus,1
0,0.831874273,2,25,GO:0042113,B cell activation,1
0,0.834172306,2,10,GO:0010888;GO:0010883;GO:1905953,regulation of lipid storage,1
0,0.840320675,-1,9,GO:0045749,obsolete negative regulation of S phase of mitotic cell cycle,1
0,0.840399108,4,17,GO:0006984,ER-nucleus signaling pathway,1
0,0.840742109,4,298,GO:0006357,regulation of transcription by RNA polymerase II,1
0,0.845014724,2,17,GO:0043112,receptor metabolic process,1
0,0.847397269,4,93,GO:0030163,protein catabolic process,1
0,0.84771796,1,325,GO:0002376,immune system process,1
0,0.847889387,5,123,GO:0045860;GO:0033674;GO:0051347,positive regulation of transferase activity,1
0,0.848633707,4,17,GO:0070536,protein K63-linked deubiquitination,1
0,0.850380551,2,7,GO:0030316,osteoclast differentiation,1
0,0.85085508,2,16,GO:0055088,lipid homeostasis,1
0,0.854220168,2,8,GO:0043087,regulation of GTPase activity,1
0,0.856223355,3,8,GO:0019430;GO:0098869;GO:1990748;GO:0098754,cellular oxidant detoxification,1
0,0.856822553,3,111,GO:0061024,membrane organization,1
0,0.859223304,4,23,GO:0043010,camera-type eye development,1
0,0.85990454,2,5,GO:0010761,fibroblast migration,1
0,0.861002183,2,5,GO:1903510,mucopolysaccharide metabolic process,1
0,0.861363817,2,8,GO:0042048,olfactory behavior,1
0,0.863489372,2,47,GO:0009791,post-embryonic development,1
0,0.864181156,2,44,GO:0007420,brain development,1
0,0.864428973,3,17,GO:0050772;GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1
0,0.864920002,7,5,GO:0050718;GO:0032731;GO:0050706;GO:0050716;GO:0032651;GO:0032732;GO:0050704;GO:0032652,positive regulation of interleukin-1 beta production,1
0,0.865980192,4,136,GO:0050776,regulation of immune response,1
0,0.867351368,3,131,GO:0045087,innate immune response,1
0,0.868026829,6,20,GO:0050728;GO:0031348;GO:0032720;GO:0032680;GO:1903556;GO:1903555,negative regulation of defense response,1
0,0.868057122,2,18,GO:1905952,regulation of lipid localization,1
0,0.869761954,2,15,GO:0032801;GO:0001919,regulation of receptor recycling,1
0,0.871300293,2,12,GO:0007422,peripheral nervous system development,1
0,0.872670835,4,5,GO:0007130;GO:0070193,synaptonemal complex assembly,1
0,0.872865317,5,10,GO:0045124;GO:0046850;GO:0034103,regulation of bone remodeling,1
0,0.876484208,3,31,GO:0007044,cell-substrate junction assembly,1
0,0.877102062,2,12,GO:0002573,myeloid leukocyte differentiation,1
0,0.877707228,2,14,GO:0002011,morphogenesis of an epithelial sheet,1
0,0.8849064,5,17,GO:0030509,BMP signaling pathway,1
0,0.886594751,2,6,GO:0010633,negative regulation of epithelial cell migration,1
0,0.889306582,3,16,GO:0016525;GO:2000181;GO:1901343,negative regulation of vasculature development,1
0,0.889620109,2,6,GO:0048661,positive regulation of smooth muscle cell proliferation,1
0,0.89000064,3,108,GO:0002253;GO:0050778,positive regulation of immune response,1
0,0.892360385,4,6,GO:0046464;GO:0046461;GO:0046503;GO:0019433,glycerolipid catabolic process,1
0,0.8938859,2,179,GO:0006955,immune response,1
0,0.894128001,2,6,GO:0003084;GO:0045777,positive regulation of blood pressure,1
0,0.894443617,2,7,GO:0021549,cerebellum development,1
0,0.894807819,2,15,GO:0071300;GO:0032526,response to retinoic acid,1
0,0.89514182,6,8,GO:0090175,regulation of establishment of planar polarity,1
0,0.897257511,2,34,GO:0006936;GO:0003012,muscle system process,1
0,0.899567515,6,19,GO:0035583;GO:0030512;GO:0035581;GO:0071694;GO:0017015;GO:1903845;GO:1900116;GO:1903844;GO:1900115,regulation of transforming growth factor beta receptor signaling pathway,1
0,0.899804238,4,213,GO:0007264,small GTPase mediated signal transduction,1
0,0.903716446,2,6,GO:0002920,regulation of humoral immune response,1
0,0.904460758,4,51,GO:0001822,kidney development,1
0,0.905853236,4,75,GO:0016050,vesicle organization,1
0,0.910108868,2,62,GO:0030855,epithelial cell differentiation,1
0,0.913523157,3,605,GO:0007166,cell surface receptor signaling pathway,1
0,0.915312469,6,17,GO:0018298,protein-chromophore linkage,1
0,0.915776455,2,90,GO:0000122,negative regulation of transcription by RNA polymerase II,1
0,0.916576858,2,23,GO:0001764,neuron migration,1
0,0.917918341,7,11,GO:0042632;GO:0055092,cholesterol homeostasis,1
0,0.923427226,2,26,GO:0071396,cellular response to lipid,1
0,0.925063679,5,7,GO:0032435;GO:1901799;GO:2000059;GO:1903051;GO:1903363,negative regulation of proteolysis involved in cellular protein catabolic process,1
0,0.925989944,4,12,GO:0045746,negative regulation of Notch signaling pathway,1
0,0.934075391,5,9,GO:0030218,erythrocyte differentiation,1
0,0.935610741,4,30,GO:0071229,cellular response to acid chemical,1
0,0.936105998,4,22,GO:0031581,hemidesmosome assembly,1
0,0.936262645,3,111,GO:0000209,protein polyubiquitination,1
0,0.937087096,4,71,GO:0002757;GO:0002764,immune response-activating signal transduction,1
0,0.938713341,3,11,GO:0002763;GO:0002761,regulation of myeloid leukocyte differentiation,1
0,0.942812874,4,10,GO:0048678,response to axon injury,1
0,0.944882055,5,9,GO:0042771;GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1
0,0.945792806,4,75,GO:0072657,protein localization to membrane,1
0,0.947617186,2,28,GO:0070534,protein K63-linked ubiquitination,1
0,0.948060148,6,10,GO:0002709;GO:0002824;GO:0002821,positive regulation of adaptive immune response,1
0,0.952518899,3,15,GO:0046579;GO:0051057,positive regulation of Ras protein signal transduction,1
0,0.955450504,2,24,GO:0002822;GO:0002819,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1
0,0.961912426,4,12,GO:0032727;GO:0032481;GO:0032647;GO:0032728,positive regulation of type I interferon production,1
0,0.964926025,3,16,GO:0008217,regulation of blood pressure,1
0,0.967327646,2,27,GO:0001707,mesoderm formation,1
0,0.97064586,5,222,GO:0070647,protein modification by small protein conjugation or removal,1
0,0.972421504,3,28,GO:0045104;GO:0045103,intermediate filament cytoskeleton organization,1
0,0.974106307,2,147,GO:0007411;GO:0097485,axon guidance,1
0,0.974184401,2,40,GO:0001704,formation of primary germ layer,1
0,0.975843299,3,14,GO:0032606,type I interferon production,1
0,0.978954872,2,177,GO:0016567;GO:0032446,protein modification by small protein conjugation,1
0,0.980360426,2,48,GO:0009611,response to wounding,1
0,0.985997109,2,21,GO:0032648,regulation of interferon-beta production,1
0,0.986474662,6,27,GO:0032480;GO:0032479,regulation of type I interferon production,1
0,0.9864877,6,20,GO:0048211;GO:0035493;GO:0048280,vesicle fusion with Golgi apparatus,1
0,0.986509436,2,39,GO:0001818,negative regulation of cytokine production,1
0,0.990123328,4,27,GO:0030099,myeloid cell differentiation,1
0,0.993345339,2,492,GO:0007155;GO:0022610,cell adhesion,1
0,0.99743613,5,120,GO:0015074,DNA integration,1
0,1,5,3804,unknown,unknown,1
0,1,2,5,GO:0000132;GO:0051294,establishment of mitotic spindle orientation,1
0,1,3,5,GO:0001542;GO:0030728,ovulation from ovarian follicle,1
0,1,2,9,GO:0001841,neural tube formation,1
0,1,2,12,GO:0002274,myeloid leukocyte activation,1
0,1,6,5,GO:0002335,mature B cell differentiation,1
0,1,3,5,GO:0002551;GO:0097531,mast cell migration,1
0,1,2,14,GO:0002637;GO:0051023,regulation of immunoglobulin production,1
0,1,4,5,GO:0002639,positive regulation of immunoglobulin production,1
0,1,5,13,GO:0002698,negative regulation of immune effector process,1
0,1,5,21,GO:0002700,regulation of production of molecular mediator of immune response,1
0,1,3,12,GO:0002702,positive regulation of production of molecular mediator of immune response,1
0,1,8,5,GO:0002726;GO:0002711;GO:0002720;GO:0002724;GO:0002718,positive regulation of T cell mediated immunity,1
0,1,2,6,GO:0002862;GO:0002861,negative regulation of inflammatory response to antigenic stimulus,1
0,1,3,5,GO:0006424;GO:0006433,glutamyl-tRNA aminoacylation,1
0,1,3,5,GO:0006438,valyl-tRNA aminoacylation,1
0,1,2,7,GO:0006509,membrane protein ectodomain proteolysis,1
0,1,2,11,GO:0006513,protein monoubiquitination,1
0,1,2,8,GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,1
0,1,2,7,GO:0006983,ER overload response,1
0,1,3,5,GO:0007158,neuron cell-cell adhesion,1
0,1,2,11,GO:0007220,Notch receptor processing,1
0,1,3,5,GO:0007379,segment specification,1
0,1,7,5,GO:0008090,retrograde axonal transport,1
0,1,4,5,GO:0009597,detection of virus,1
0,1,2,5,GO:0009737,response to abscisic acid,1
0,1,4,8,GO:0009751,response to salicylic acid,1
0,1,2,5,GO:0009949;GO:0065001,polarity specification of anterior/posterior axis,1
0,1,3,5,GO:0016246,RNA interference,1
0,1,5,12,GO:0016574,histone ubiquitination,1
0,1,7,7,GO:0016601,Rac protein signal transduction,1
0,1,3,9,GO:0017145,stem cell division,1
0,1,5,7,GO:0019227;GO:0098870,action potential propagation,1
0,1,5,5,GO:0021983,pituitary gland development,1
0,1,5,6,GO:0030282,bone mineralization,1
0,1,5,14,GO:0030595;GO:0060326;GO:0097529,cell chemotaxis,1
0,1,4,5,GO:0031103;GO:0031102;GO:0061564,axon regeneration,1
0,1,2,6,GO:0031293,membrane protein intracellular domain proteolysis,1
0,1,2,6,GO:0031645,negative regulation of neurological system process,1
0,1,3,9,GO:0031929,TOR signaling,1
0,1,2,6,GO:0032092,positive regulation of protein binding,1
0,1,2,6,GO:0032148,activation of protein kinase B activity,1
0,1,3,7,GO:0032456,endocytic recycling,1
0,1,2,8,GO:0032608,interferon-beta production,1
0,1,5,5,GO:0032653,regulation of interleukin-10 production,1
0,1,2,11,GO:0032715,negative regulation of interleukin-6 production,1
0,1,2,7,GO:0032869;GO:0046324,cellular response to insulin stimulus,1
0,1,2,16,GO:0033209,tumor necrosis factor-mediated signaling pathway,1
0,1,-1,7,GO:0033261,obsolete regulation of S phase,1
0,1,2,5,GO:0033523,histone H2B ubiquitination,1
0,1,2,12,GO:0033619,membrane protein proteolysis,1
0,1,-1,8,GO:0034339,obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor,1
0,1,2,7,GO:0035194;GO:0016441,posttranscriptional gene silencing,1
0,1,2,5,GO:0035459,vesicle cargo loading,1
0,1,2,9,GO:0035567,non-canonical Wnt signaling pathway,1
0,1,5,6,GO:0036230;GO:0042119;GO:0030854;GO:0030852,positive regulation of granulocyte differentiation,1
0,1,5,8,GO:0040024,dauer larval development,1
0,1,4,6,GO:0042036,negative regulation of cytokine biosynthetic process,1
0,1,2,5,GO:0042554,superoxide anion generation,1
0,1,2,6,GO:0042733,embryonic digit morphogenesis,1
0,1,3,9,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1
0,1,3,8,GO:0043496,regulation of protein homodimerization activity,1
0,1,7,6,GO:0045123;GO:0030593;GO:0071621;GO:1990266;GO:0097530,neutrophil migration,1
0,1,2,8,GO:0045199;GO:0035090,maintenance of apical/basal cell polarity,1
0,1,5,5,GO:0045806;GO:0070086,negative regulation of endocytosis,1
0,1,5,9,GO:0046622,positive regulation of organ growth,1
0,1,4,6,GO:0046717,acid secretion,1
0,1,4,7,GO:0046755,viral budding,1
0,1,2,6,GO:0046797,viral procapsid maturation,1
0,1,3,5,GO:0046902;GO:0090559,regulation of mitochondrial membrane permeability,1
0,1,4,5,GO:0048147,negative regulation of fibroblast proliferation,1
0,1,3,6,GO:0048557,embryonic digestive tract morphogenesis,1
0,1,4,22,GO:0048675;GO:1990138,axon extension,1
0,1,2,20,GO:0050688,regulation of defense response to virus,1
0,1,3,9,GO:0050691,regulation of defense response to virus by host,1
0,1,2,6,GO:0050731;GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1
0,1,3,8,GO:0050795,regulation of behavior,1
0,1,4,11,GO:0050856;GO:0050854,regulation of T cell receptor signaling pathway,1
0,1,2,11,GO:0051568;GO:0001555,histone H3-K4 methylation,1
0,1,3,5,GO:0060148;GO:0060147,positive regulation of posttranscriptional gene silencing,1
0,1,2,6,GO:0060441;GO:0061304;GO:0061299,epithelial tube branching involved in lung morphogenesis,1
0,1,2,9,GO:0060445,branching involved in salivary gland morphogenesis,1
0,1,2,8,GO:0060997;GO:0097061;GO:0099173;GO:0106027,dendritic spine morphogenesis,1
0,1,4,6,GO:0071222,cellular response to lipopolysaccharide,1
0,1,3,7,GO:0071555;GO:0045229;GO:0071554,cell wall organization,1
0,1,5,5,GO:0072499,photoreceptor cell axon guidance,1
0,1,2,8,GO:2000273;GO:0010469,regulation of signaling receptor activity,1
0,0.002109811,2,18,GO:0000381,regulation of alternative mRNA splicing,
0,0.003359312,-1,5,GO:0000059,obsolete protein import into nucleus,
0,0.00725186,2,42,GO:0000398;GO:0000377;GO:0000375,RNA splicing,
0,0.007737018,-1,6,GO:0000060,obsolete protein import into nucleus,
0,0.009512251,2,15,GO:0006368;GO:0006354,DNA-templated transcription,
0,0.011101762,2,11,GO:0042147,retrograde transport,
0,0.020052314,3,7,GO:0035152,regulation of tube architecture,
0,0.024287022,2,5,GO:0040034,regulation of development,
0,0.034776812,3,6,GO:0046529,imaginal disc fusion,
0,0.037579299,3,7,GO:0006930,substrate-dependent cell migration,
0,0.057013572,5,14,GO:0006353,DNA-templated transcription,
0,0.109153216,2,22,GO:0050792;GO:0043903,regulation of symbiosis,
0,0.1189098,3,33,GO:0000184,nuclear-transcribed mRNA catabolic process,
0,0.193683291,2,10,GO:0006890,retrograde vesicle-mediated transport,
0,0.214401044,6,35,GO:0006352,DNA-templated transcription,
0,0.224746547,2,37,GO:0040029,regulation of gene expression,
0,0.467503992,2,14,GO:0006313;GO:0032196,transposition,
0,0.48141198,2,9,GO:0006958,complement activation,
0,0.521893662,6,13,GO:0007188;GO:0007187,G protein-coupled receptor signaling pathway,
0,0.597795024,2,9,GO:0051966,regulation of synaptic transmission,
0,0.614964303,2,5,GO:0035249,synaptic transmission,
0,0.706475179,2,7,GO:0032786,positive regulation of DNA-templated transcription,
0,0.830370314,5,20,GO:0035278;GO:0040033;GO:0045974;GO:0045947,regulation of translation,
0,0.920366807,3,14,GO:0032784,regulation of DNA-templated transcription,
0,1,2,10,GO:0006911;GO:0099024;GO:0010324,phagocytosis,
0,1,6,8,GO:0030970;GO:0032527;GO:1903513,retrograde protein transport,
0,1,3,5,GO:0060071,Wnt signaling pathway,